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Abstract 
 
In vitro and ex vivo antioxidant activity of Casimiroa spp, Croton lechleri, Ribes 
nigrum, and Boswellia serrata in atherosclerosis prevention 
 
Oxidative and glycoxidative stress are postulated to be the primary events in the 
pathogenesis of type 2 diabetes mellitus and its vascular implications. Further, LDL 
oxidation in the vessel wall plays a key role in atherogenesis, also related to damage 
from oxygen species (ROS). Moreover, the risk for development of atherosclerosis is 
by approximately three-fold increased in patients with diabetes. The medicinal plants 
are widely used in folk medicine for the treatment of cardiovascular diseases and 
diabetes mellitus. The genus Casimiroa (Rutaceae) includes few species which have 
their habitat in Central America and Mexico; among these, the most common are 
Casimiroa edulis Llave et lex. and Casimiroa pubescens Ramirez. The decoction of 
leaves and seeds are traditionally used for treating hypertension. The sap of Croton 
lechleri (Euphorbiaceae), a South American tree, is used topically in the treatment of 
wound healing and orally, in a dilute form, mainly for gastric ulcers and intestinal 
diseases. The gum resin of Boswellia serrata (Burseraceae), which grows in dry 
mountainous regions of India, Northern Africa and Middle East, has been traditionally 
used to treat various chronic inflammatory diseases. Ribes nigrum (Grossulariaceae), 
a species native to central and northern Europe and northern Asia, is a traditional 
medicine for the treatment of inflammatory disorders such as rheumatic diseases.  
The aim of this research was to investigate the antioxidant activity of these medicinal 
plants by means of several experimental methods in vitro and ex vivo to outline their 
role in the prevention and/or treatment of cardiovascular diseases related to 
oxidative stress. 
The antioxidant activity was evaluated by DPPH· method, and ORAC (Oxygen Radical 
Absorbance Capacity) assay. Also, the total phenolic content (TPC) was determined 
by the use of Folin-Ciocalteu reagent, and the total flavonoid content (TFC) by 
complexation with chloride aluminium. The activity of the plant extracts on LDL 
oxidation was studied by monitoring the formation of conjugated dienes, and the 
quantification of thiobarbituric acid reactive substances (TBARS). Finally, their 
inhibitory effect on advanced glycation end products (AGEs) formation were 
evaluated by means of BSA-glucose/ribose fluorescence assay.  
In DPPH· assay, Croton lechleri sap and blackcurrant (Ribes nigrum) bud extract 
showed higher scavenging activity in comparison with Casimiroa extracts, whereas in 
the ORAC assay the Casimiroa leaf extracts showed a high ORAC value and Croton 
lechleri an activity even higher. In TPC test, Croton lechleri showed the highest value 
(713.76 ± 32.23 mg GAE/g). In the LDL oxidation assay, the plant extracts exhibited 
considerable protective effects by prolonging the oxidation lag phase; for example, at 
the concentration of 0.8 µg/ml Croton lechleri increased the lagtime by 58.6%, and 
in the antiglycation study all extracts inhibited the AGEs formation significantly in the 
BSA-glucose model. The results from this research suggest that the medicinal plants 
Croton lechleri, Casimiroa spp. and Ribes nigrum, even if in different manner, may 
have implications in the prevention of atherosclerotic vascular diseases, whereas 
Boswellia serrata showed a minor role. 
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Abstract 
 
Studio in vitro ed ex vivo dell’attività antiossidante di Casimiroa spp, Croton lechleri, 
Ribes nigrum e Boswellia serrata nella prevenzione dell’aterosclerosi 
 
Si ritiene che lo stress ossidativo e glicossidativo sia uno degli eventi primari nella 
patogenesi del diabete mellito di tipo 2 e delle sue implicazioni vascolari. Inoltre, 
l'ossidazione delle lipoproteine a bassa densità (LDL) all’interno delle pareti vascolari 
svolge un ruolo chiave nel processo di aterogenesi, oltre ad essere correlata ai danni 
prodotti dalle specie reattive dell'ossigeno (ROS). Peraltro, il rischio di sviluppo di 
aterosclerosi è di circa tre volte maggiore nei pazienti affetti da diabete. Le piante 
medicinali sono ampiamente utilizzate nella medicina popolare per il trattamento 
delle malattie cardiovascolari e del diabete mellito. Il genere Casimiroa (Rutaceae) 
comprende alcune specie il cui habitat è America Centrale e Messico; tra queste, le 
specie più comuni sono Casimiroa edulis Llave et lex. e Casimiroa pubescens 
Ramirez. Il decotto di foglie e semi è tradizionalmente utilizzato per il trattamento 
dell'ipertensione. Il latice di Croton lechleri (Euphorbiaceae), un albero 
sudamericano, viene utilizzato come cicatrizzante per uso topico, e, per via orale in 
forma diluita, per il trattamento di ulcere gastriche e malattie intestinali. La resina 
gommosa di Boswellia serrata (Burseraceae), pianta che cresce nelle regioni aride 
montuose di India, Nord Africa e Medio Oriente, è tradizionalmente usata per il 
trattamento di varie malattie infiammatorie croniche. Ribes nigrum 
(Grossulariaceae), una specie originaria dell'Europa centrale e settentrionale e Asia 
settentrionale , è utilizzato in medicina tradizionale per il trattamento di malattie 
infiammatorie come le malattie reumatiche. 
Lo scopo di questa ricerca prevede lo studio dell'attività antiossidante di queste 
piante medicinali mediante diversi metodi sperimentali in vitro ed ex vivo, per 
delineare il loro ruolo nella prevenzione e/o trattamento di malattie cardiovascolari 
legate allo stress ossidativo. 
L'attività antiossidante è stata valutata tramite il saggio DPPH• e il saggio ORAC 
(Oxygen Radical Assorbanza Capacity). Inoltre, sono stati valutati il contenuto 
fenolico totale (TPC), mediante l'uso del reattivo di Folin-Ciocalteu, e il contenuto di 
flavonoidi totale (TFC), mediante complessazione con alluminio cloruro. L'attività 
degli estratti vegetali sull'ossidazione delle LDL è stata studiata monitorando la 
formazione di dieni coniugati, e la quantificazione di sostanze reattive dell'acido 
tiobarbiturico (TBARS). Infine , il loro effetto inibitorio sulla formazione di prodotti 
finali della glicazione avanzata (AGE) è stato valutato mediante test fluorimetrico con 
BSA-glucosio/ribosio. 
Dai risultati ottenuti tramite il saggio DPPH•, si osserva che il latice di Croton lechleri 
e il gemmoderivato di ribes nero (Ribes nigrum) hanno mostrato un'attività 
scavenging più elevata rispetto agli estratti di Casimiroa, mentre nel saggio ORAC gli 
estratti di foglie di Casimiroa hanno mostrato un elevato valore di capacità 
antiossidante, e il latice di Croton lechleri un'attività ancora più elevata. Nel saggio 
TPC, Croton lechleri ha mostrato il valore più alto (713,76 ± 32,23 mg GAE/g). Nel 
saggio di ossidazione delle LDL, gli estratti vegetali hanno mostrato effetti protettivi 
notevoli prolungando la fase di latenza di ossidazione; ad esempio, alla 
concentrazione di 0,8 mg/ml Croton lechleri ha determinato un prolungamento del 
tempo di latenza del 58,6%. Nello studio antiglicativo tutti gli estratti hanno 
significativamente inibito la formazione di AGEs nel modello BSA-glucosio. I risultati 
di questa ricerca suggeriscono che le piante medicinali Casimiroa spp., Croton lechleri 
e Ribes nigrum, anche se in modo diverso, possono avere implicazioni nella 
prevenzione delle malattie vascolari aterosclerotiche, mentre Boswellia serrata risulta 
possedere un ruolo minore. 
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ABBREVIATIONS 
 
O
2
·
−
: superoxide 
.
OH: hydroxyl radical 
1
O2: singlet oxygen 
A
.
: radical 
A
+.
: radical cation 
AAPH: 2,2'-Azobis(2-amidinopropane) dihydrochloride 
AGEs: advanced glycosylation end products 
AH: antioxidant 
AOC: antioxidant capacity 
ApoB: apolipoprotein B  
ATP: adenosine triphosphate 
ASC: ascorbic acid 
AUC: area under the curve 
bFGF: basic fibroblast growth factor 
BHA: butylated hydroxyanisole 
BHT: butylated hydroxytoluene 
Bs: oleo-gum extract of Boswellia serrata 
BSA: Albumine Bovine fraction V lyophilized powder 
CAT: catalase 
CD59: CD59 glycoprotein 
Ce1: methanolic seed extract of Casimiroa edulis 
Ce2: aqueose leaf extract of Casimiroa edulis 
CML: carboxymethyl-lysine 
Cp1: methanolic seed extract of Casimiroa pubescens 
Cp2: methanolic leaf extract of Casimiroa pubescens 
CuSO4: copper sulphate 
CVD: cardiovascular disease 
DMSO: dimethyl sulfoxide 
DNA: deoxyribonucleic acid 
DPPH: 2,2-diphenyl-1-picrylhydrazyl 
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EC: endothelial cell 
EC50: half maximal effective concentration 
EDTA: ethylenediaminetetraacetic acid  
FDA: Food and Drug Administration 
FL: fructose-lysine 
FoxLDL: fully oxidized LDL 
GAE: gallic acid equivalents 
GPx: glutathione peroxidase 
GSH: glutathione 
H2O2: hydrogen peroxide 
HAT: hydrogen atom transferring 
HDL: high-density lipoprotein 
HIV/AIDS: human immunodeficiency virus infection / acquired immunodeficiency 
syndrome 
HUVEC: human umbilical vein endothelial cells 
IGF-1: insulin-like growth factor 1 
IL-1: interleukin 1 family 
LDL: low-density lipoprotein 
LOO•: lipid peroxy radical 
LOOH: lipid hydroperoxide 
LOX-1: lectin-like Ox-LDL receptor 
Mφ: macrophages 
MCP-1: monocytes chemoattractant protein-1 
MCSF: macrophage colony stimulating factor 
MDA: malondialdehyde 
MM-LDL: minimally modified LDL 
MMP: matrix metalloproteinases 
MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide  
NF-κB: epidermal growth factor 
NO·: nitric oxide  
ORAC: oxygen radical absorbance capacity 
Ox-LDL: oxidized low-density lipoprotein 
PBS: phosphate buffered saline 
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pD2: -log EC50 
PDGF: platelet-derived growth factor 
QE: quercetin equivalents 
RCS: reactive carbonyl species 
Rn: 2% hydroalcoholic solution of the extract of the buds of Ribes nigrum 
RNS: reactive nitrogen species 
ROS: reactive oxygen species 
SdD: dry residue obtained by lyophilisation of Croton lechleri sap 
SET: single electron transfering 
SMC: smooth muscle cell 
SOD: superoxide dismutase  
SRs: scavenger receptors 
TBA: thiobarbituric acid  
TBARS: thiobarbituric acid reactive substances 
TCA: trichloroacetic acid  
TEAC: trolox equivalent antioxidant capacity 
TFC: total flavonoid content 
TNF-α: tumor necrosis factor 
TPC: total phenolic content 
VSMC: vascular smooth muscle cells 
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INTRODUCTION 
 
- Atherosclerosis 
Cardiovascular diseases (CVDs) are the leading cause of death globally: more people die 
annually from CVDs than any other cause. About 17.3 million people died from CVDs in 
2008, representing 30% of all global deaths (Alwan, 2011); of these deaths, an estimated 
7.3 million were due to coronary heart disease and 6.2 million were due to stroke (Global 
atlas on cardiovascular disease prevention and control2011)               . 
Atherosclerosis is regarded as a dynamic and progressive disease arising from the 
combination of endothelial dysfunction and inflammation. This pathological condition, 
commonly referred to as a hardening or furring of the arteries (Maton, 1993), is a specific 
form of arteriosclerosis in which an artery wall thickens as a result of the accumulation of 
calcium and fatty materials such as cholesterol and triglyceride. It is a chronic 
inflammatory response in the arterial walls affecting blood vessels caused largely by the 
accumulation of macrophages and white blood cells and promoted by low-density 
lipoproteins (LDL), without adequate removal of fats and cholesterol from the 
macrophages by functional high-density lipoproteins (HDL). It is caused by the formation 
of multiple plaques within the arteries. The atheromatous plaque usually has three distinct 
components: 
1. the atheroma ("lump of gruel", from greek ἀθήρα (athera), meaning "gruel"), 
which is the nodular accumulation of a soft, flaky, yellowish material at the center 
of large plaques, composed of macrophages nearest the lumen of the artery;  
2. underlying areas of cholesterol crystals;  
3. calcification at the outer base of older/more advanced lesions.  
Atherosclerosis is a chronic disease that remains asymptomatic for decades (Ross, 1993). 
Atherosclerotic lesions or atherosclerotic plaques are separated into two broad categories: 
stable and unstable, also called vulnerable (Ross, 1999). The pathobiology of 
atherosclerotic lesions is very complicated but generally, stable atherosclerotic plaques, 
which tend to be asymptomatic, are rich in extracellular matrix and smooth muscle cells, 
while, unstable plaques are rich in macrophages and foam cells and the extracellular 
matrix separating the lesion from the arterial lumen (also known as the fibrous cap) is 
usually weak and prone to rupture (Finn, Nakano, Narula, Kolodgie, & Virmani, 2010). 
Ruptures of the fibrous cap expose thrombogenic material, such as collagen to the 
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circulation and eventually induce thrombus formation in the lumen (Didangelos, Simper, 
Monaco, & Mayr, 2009). Upon formation, intraluminal thrombi can occlude arteries 
outright (e.g. coronary occlusion), but more often they detach, move into the circulation 
and eventually occluding smaller downstream branches causing thromboembolism. Apart 
from thromboembolism, chronically expanding atherosclerotic lesions can cause 
complete closure of the lumen. Interestingly, chronically expanding lesions are often 
asymptomatic until lumen stenosis is so severe (usually over 80%) that blood supply to 
downstream tissue(s) is insufficient, resulting in ischemia. 
These complications of advanced atherosclerosis are chronic, slowly progressive and 
cumulative. Most commonly, soft plaque suddenly ruptures, causing the formation of a 
thrombus that will rapidly slow or stop blood flow, leading to death of the tissues fed by 
the artery in approximately 5 minutes, resulting in an infarction. A coronary thrombosis of 
a coronary artery cause myocardial infarction (a heart attack), and the same process in an 
artery to the brain cause a stroke. A combination of both stenosis and aneurysmal 
segments narrowed with clots in very advanced disease can cause a claudication from 
insufficient blood supply to the legs. 
Atherosclerosis affects the entire artery tree, in particular larger, high-pressure vessels 
such as the coronary, renal, femoral, cerebral, and carotid arteries. These are termed 
"clinically silent" when infarctions involve only very small amounts of tissue and the 
person having the infarction does not notice the problem and does not seek medical help, 
or when they do, physicians do not recognize what has happened. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Representation of the progression of atherosclerosis. 
From: http://en.wikipedia.org/wiki/Atherosclerosis 
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The lipid peroxidation, the hallmark of fatty streak formation, is the earliest manifestation 
of atherosclerosis. Macrophages (Mφ) take up unmodified (native) LDL at low regulated 
rates, whereas structurally modified LDL (Ox-LDL) is avidly taken up by Mφ to form 
foam cells (Brown & Goldstein, 1983). This occurs at uncontrolled rates, not subject to 
negative feedback, via specific scavenger receptors (SRs) (Nedeljkovic, Gokce, & 
Loscalzo, 2003; Steinberg & Witztum, 2002). These findings provided the theory that 
Ox-LDL plays a pivotal role in atherosclerotic initiation and development; providing a 
mechanistic link between hypercholesterolaemia and CVD. 
Native LDL accumulates in the extracellular subendothelial space of arteries and can be 
oxidatively modified by all major arterial wall cell types, including endothelial cells, 
Vascular Smooth Muscle Cells (VSMC) and Mφ (Ting et al., 1997). Both the lipid and 
protein moieties of lipid particles can be oxidized, yielding a broad spectrum of Ox-LDL 
species, differing structurally and functionally, dependent on the degree of oxidative 
modification (Steinberg & Witztum, 2002). 
Three lines of evidence support that LDL in vivo oxidation contributes to the formation 
and progression of atherosclerotic plaques. First, oxidatively modified LDL accumulates 
and is extracted from atherosclerotic lesions, correlating with atherosclerotic risk 
(Chisolm, Hazen, Fox, & Cathcart, 1999). Second, immunohistochemistry reveals that 
epitopes in atherosclerotic lesions react with antibodies raised against Ox-LDL. Third, 
human and animal studies demonstrate the presence of autoantibodies, which react with 
Ox-LDL, suggesting the presence of Ox-LDL in vivo, or a similar epitope (Steinberg, 
1997). 
Human ex vivo data on lipid peroxidation showed a significant positive correlation 
between patients with acute coronary syndromes and plasma/arterial wall Ox-LDL levels 
in coronary atherectomy specimens (Ehara et al., 2001). This evidence supports previous 
investigations (Toshima et al., 2000) suggesting that plasma Ox-LDL may be a useful 
marker of CVD. The power of plasma Ox-LDL to predict the burden of atherogenesis, 
and the type of epitope most representative of Ox-LDL in vivo remains to be determined 
(Tsimikas & Witztum, 2001).  
Ox-LDL can be indirectly atherogenic by inducing extensive humoral and cellular 
responses; extending beyond foam cell formation. Both minimally modified LDL (MM-
LDL) and fully oxidized LDL (FoxLDL) stimulate monocyte-endothelial cell interactions 
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and the expression of adhesion molecules in different ways; promoting atherogenesis and 
plaque instability (Frei, 1999). MM-LDL can stimulate pro-inflammatory signals causing 
increased adherence and penetration of monocytes to endothelial cells via inducing 
expression of monocytes chemoattractant protein-1 (MCP-1) and macrophage colony 
stimulating factor (MCSF), stimulating Mφ differentiation and up-regulation of SRs 
(Steinberg, 1997). 
By contrast, LOX1’s major ligand FoxLDL which is directly chemotactic for monocytes, 
VSMC, and T cells; stimulates Mφ and VSMC mitosis; induces endothelial cell 
cytotoxicity and inhibits Mφ motility (Frei, 1999). Additionally, in cell culture studies, 
FoxLDL stimulates juxtaglomerular cell renin release in the kidney, associated with 
enhanced O2
−
 production (Galle & Heermeier, 1999). Moreover, experimental evidence 
suggests that the binding of Ox-LDL with LOX-1 induces ROS production, VSMC 
apoptosis and modulation of MMP activity, potentially causing plaque instability 
(Szmitko et al., 2003; Thomson, Puntmann, & Kaski, 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Representation of the sequences of cellular interactions in developing 
atherosclerosis. From: (Kumar, Vinay,, Abbas, Abul K., Fausto, Nelson., Robbins, Stanley L., 
Cotran,Ramzi S.,, 2005) 
 
 
 
- ROS and Antioxidants 
Reactive oxygen species (ROS) are highly reactive molecules or molecular fragments that 
are continuously produced in all aerobic organisms, mostly as a consequence of aerobic 
respiration. With the help of the mitochondrial respiratory chain, aerobic organisms are 
able to attain a far greater energy production efficiency compared to anaerobic organisms. 
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However, one disadvantage of aerobic respiration is continuous electron leakage to O
2
 
during mitochondrial ATP synthesis. 1–5% of total oxygen consumed in aerobic 
metabolism therefore produces the superoxide anion, (O
2
·
−
), the first reduction product of 
O
2
 (Dreher & Junod, 1996). Besides oxidative phosphorylation, low levels of ROS are 
continuously formed in peroxisomes, the cytochrome P450 system and inflammatory 
cells, including neutrophils, eosinophils and macrophages. Some exogenous sources of 
radicals also exist, including ionizing radiation, ozone, and many chemotherapeutic drugs. 
The term ROS covers several types of reactive oxygen metabolites, including free 
radicals, which are defined as a molecule containing one or more unpaired electrons on its 
outermost orbital, for example, superoxide anion (O
2
·
−
), hydroxyl radical (·OH) and 
singlet oxygen 
1
O2, (Tab. 1) (Wiseman & Halliwell, 1996). The term ROS also 
encompasses some non-radicals such as hydrogen peroxide (H
2
O
2
). The life-span of 
different ROS varies considerably, from less than 1 ns of ·OH to even hours of H
2
O
2
, 
depending on numerous cellular environment factors (Valko, Izakovic, Mazur, Rhodes, & 
Telser, 2004). Besides the high reactivity, another important feature of ROS is that their 
reactions with non-radicals tend to result in the formation of new radicals. 
The term ROS can also be taken to cover nitric oxide-derived reactive molecules, such as 
peroxynitrite. These molecules play important roles in many physiological processes; 
however, if the amount of ROS exceeds the capacity of the ROS-suppressing machinery, 
oxidative stress is said to occur. This imbalanced redox status is sufficiently potent to 
induce damage in all cellular macromolecules, including DNA (Wiseman & Halliwell, 
1996). ROS are nowadays considered as a significant class of carcinogens participating in 
cancer initiation, promotion and progression (Klaunig et al., 1998). However, they also 
have important roles in intracellular and intercellular signaling. Nowadays H
2
O
2
 is 
recognized as a key intracellular messenger at subtoxic levels in certain important signal 
pathways, such as epidermal growth factor and NF-κB activation (Bae et al., 1997; Rhee, 
1999). In addition, H
2
O
2
 plays a crucial role as a mediator of the effects of platelet-
derived growth factor (PDGF), epidermal growth factor and angiotensin II. This is 
underlined by the observation that all of these signaling pathways are completely blocked 
after the specific inhibition of H
2
O
2
 (Bae et al., 1997; Sundaresan, Yu, Ferrans, Irani, & 
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Finkel, 1995; Ushio-Fukai et al., 1999). H
2
O
2
 and NO· are also involved essentially in 
apoptotic pathways (Finkel, 1998; Karihtala & Soini, 2007).  
 
 
                  Table 1. Formation of the biologically most important reactive oxygen species. 
 
Reaction Note 
O2+e
−→O2
·−
 Superoxide formation (various sources) 
2 O2
·−
+2 H
+→H2O2+O2 Hydrogen peroxide formation, catalyzed by SODs 
Fe
2+
+H2O2→Fe
3+
+·OH+OH
−
 Fenton reaction 
O2
·−
+H2O2→·OH+OH
−
+O2 Haber-Weiss reaction (iron-catalyzed) 
 
Exposure to free radicals from a variety of sources has led organisms to develop a series 
of defence mechanisms (Cadenas, 1997). Defence mechanisms against free radical-
induced oxidative stress involve: (i) preventative mechanisms, (ii) repair mechanisms, 
(iii) physical defences, and (iv) antioxidant defences. Enzymatic antioxidant defences 
include superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT). 
Non-enzymatic antioxidants are represented by ascorbic acid (Vitamin C), α-tocopherol 
(Vitamin E), glutathione (GSH), carotenoids, flavonoids, and other antioxidants. Under 
normal conditions, there is a balance between both the activities and the intracellular 
levels of these antioxidants. This balance is essential for the survival of organisms and 
their health (Valko et al., 2007). 
 
Based on their mechanism of action, the antioxidants can be divided in two types. 
- Type Ι : "Chain breaker" .  
They are able to inactivate free radicals by donating hydrogen atom or transferring a 
single electron to the free radical species. They are compounds that, thanks to their 
negative redox potential, are able to provide electrons to the free radicals, thus restoring 
the chemical balance of the system. Their effectiveness depends on the stability of the 
radicals in which they are transformed; therefore, the more efficient the delocalization of 
unpaired electrons produced in the reaction with free radicals, the greater its antioxidant 
power. Antioxidants of this type can dis-activate the radical species through two basic 
mechanisms: by transfer of a hydrogen atom (Hydrogen Atom Transfer, HAT) or by 
transfer of a single electron (Single Electron Transfer, SET). The final result is the same, 
but the kinetics and the potential of the reactions are different (Prior, Wu, & Schaich, 
2005). In reality, these mechanisms may also take place at the same time, but it will be 
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chemical structure of antioxidant, together with its solubility properties, partition 
coefficient and solvent, to determine the prevalent mechanism of action. The bond-
dissociation energy and the ionization potential are the two main factors that affect the 
mechanism and efficiency of antioxidant (Wright, Johnson, & DiLabio, 2001). 
Antioxidants "donors of a hydrogen atom" act according to the following scheme: 
 
X· + AH → XH + A· 
 
Generally, one substance can act as an antioxidant if once oxidized, its radical form is not 
reactive or little reactive towards other molecules. HAT reactions are solvent and pH 
independent and, generally occur quite quickly, ending in a few seconds or a few minutes. 
Conversely, reactions SET shall run slowly and are pH-dependent. SET-based methods 
detect the ability of a potential antioxidant to transfer one electron to reduce any 
compound, including metals, carbonyls, and radicals: 
 
 
X· + AH → X- + AH·+ 
AH·
+ 
+ H2O ↔ A· + H3O
+
 
X
-
 + H3O
+
 → XH + H2O 
M(III) + AH → AH+ + M(II) 
 
Belong to this group of antioxidants tert-butyl-hydroxyanisole (BHA), the tert-butyl 
hydroxytoluene (BHT), tert-butyl-hydroxyquinone (TBHQ), propyl-gallate (PG), 
tocopherols and phenolic compounds. 
- Type ΙI: "Metal scavenger". Prevent the formation of free radicals by acting as 
metal chelating agents. Metal ions such as iron or copper are potent pro-oxidants 
that accelerate lipid oxidation lowering the activation energy of the reactions of 
initiation, generating alkyl radicals from fatty acids (1) or inducing the formation 
of singlet oxygen (much more reactive than normal triplet oxygen present in the 
air that we breathe) mediated by superoxide anion (2): 
 
Fe
3+
 + RH Fe
3+
 + R·                                 (1) 
Fe
2+
 + 
3
O2 Fe
3+
 + O2
-
·  
1
O2
*
 + e-           (2) 
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The metals also perpetuate lipid oxidation, producing free radicals via the Fenton reaction 
(3). This reaction is the major source of formation of alkoxy radicals, which are the most 
reactive and damaging ROS in biological systems: 
 
                                         Fe
2+
 + H2O2 Fe
3+
 + OH· + OH
-
                   (3) 
Other free radicals formed by the metals are produced from the decomposition of lipid 
hydroperoxides (reactions (4) and (5)), in which the metal reacts either in the reduced 
form (Fe
2+
) or in the oxidized form (Fe
3+
); the latter, however, was found to produce 
radicals at a rate 10 times lower. 
 
                                        Fe
2+
 + ROOH         Fe
3+
 + RO· + OH
-                  
(4) 
                                        Fe
3+
 + ROOH       Fe
2+
 + ROO· + H
+
             (5) 
 
 
Examples of metal-acid scavenger are ethylenediaminetetraacetic acid (EDTA) (Fig. 3), 
citric acid, ascorbic acid and some amino acids. 
 
Figure 3. Chemical structure of Metal-EDTA chelate. 
 
In nature, between the two classes of antioxidants there are not so precise limits; 
substances such as phenolic compounds can behave simultaneously both as chain breaker 
and as metal scavenger.  
 
The plaque formation is proposed to be initiated at sites of endothelial damage inducing 
adhesion molecule and chemotactic factor expression. This leads to the tethering, 
activation and attachment of monocytes and T lymphocytes to endothelial cells, with 
consequent migration into the subendothelial space. Transformation of monocytes into 
macrophages (Mφ) generates further ROS which, alongside potential ROS production 
from other cell types, generates oxidized low density lipoprotein (Ox-LDL) promoting 
foam cell formation. Foam cells on combining with leucocytes formulate fatty streaks 
which can, with continued down-stream effects of ROS alongside inflammatory 
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pathways, contribute to advanced plaque formation encouraging plaque instability and 
thrombotic events (Madamanchi, Vendrov, & Runge, 2005; McCormick, Gavrila, & 
Weintraub, 2007). Fig. 4 demonstrates the proposed mechanisms of ROS production and 
plaque formation.  
 
 
 
Figure 4. Summary of the role of ROS in plaque formation. From: (Thomson et al., 2007) 
 
ROS generation causes apoptosis via caspase induction and collagen matrix degradation 
by activating matrix metalloproteinases (MMP), factors implicated in plaque instability 
(Irani, 2000; Nedeljkovic et al., 2003). Collagen, an important component of the matrix of 
atheromatous plaques is generated by a vitamin C-dependent process (Libby & Aikawa, 
2002). Thus, at least theoretically, antioxidant vitamins may be significant in stabilizing 
plaques and inhibiting or slowing down advanced atheroma formation and disruption. 
 
- Hyperglycaemia promotes atherosclerosis 
Atherosclerosis is a leading cause of morbidity and mortality in patients suffering from 
diabetes mellitus. The risk for development of atherosclerosis is increased by 
approximately three fold in patients with diabetes as a result of a number of processes 
which are still poorly understood. One hypothesis is that increase modification of low 
density lipoprotein (LDL) by oxidation and/or glycation may enhance the atherogenic 
process in individual with diabetes. There is increasing evidence that both LDL and 
plasma from individuals with diabetes may be more susceptible to oxidation 
(RW.ERROR - Unable to find reference:93). 
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One of the important possible mechanisms responsible for the accelerated atherosclerosis 
in diabetes is the non-enzymatic reaction between glucose and proteins or lipoproteins in 
arterial walls, collectively known as Maillard, or browning reaction. Glucose forms 
chemically reversible early glycosylation products with reactive amino groups of 
circulating or vessel wall proteins (Schiff bases), which subsequently rearrange to form 
the more stable Amadori-type early glycosylation products. Equilibrium levels of Schiff-
base and Amadori products (the best known of which is hemoglobin A1C) are reached in 
hours and weeks, respectively (Fig. 5). Some of the early glycosylation products on long-
lived proteins (e.g. vessel wall collagen) continue to undergo complex series of chemical 
rearrangement to form advanced glycosylation end products (AGEs). Once formed, AGE-
protein adducts are stable and virtually irreversible. Although AGEs comprise a large 
number of chemical structures, carboxymethyl-lysine-protein adducts are the in vivo 
predominant AGEs (Aronson & Rayfield, 2002).  
 
 
Figure 5. Formation of advanced glycosylation end products (AGEs). From: (Aronson & 
Rayfield, 2002) 
 
 
AGEs can accelerate the atherosclerotic process by diverse mechanisms, which can be 
classified as non-receptor dependent and receptor-mediated. 
- Non-receptor dependent mechanisms includes the cross-linking collagen and 
enhanced synthesis of extracellular matrix compounds, trapping of LDL, and 
quenching of nitric oxides; functional alterations of regulatory proteins such as bFGF 
and complement regulatory protein CD59; lipoprotein modifications, such as LDL 
glycosylation, reduced LDL receptor recognition, and increased susceptibility of 
LDL to oxidative modification (Fig. 6). 
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Figure 6. Potential mechanisms by which LDL glycosylation increases the atherogenicity. 
Advanced glycosylation of the phospholipid component of LDL is accompanied by the 
progressive oxidative modification of unsaturated fatty acid residues. Glycosylation of LDL 
apoB reduces its recognition by the LDL receptor and increases uptake through the scavenger 
receptor. From: (Aronson & Rayfield, 2002) 
 
Receptor mediated mechanism involves promoting inflammation, secretion of cytokines 
such as TNF-α, IL-1, etc.; induction of cellular proliferation, such as stimulation of PDGF 
and IGF-1 secretion from monocytes and possibly SMC; and endothelial dysfunction, 
such as increased permeability of EC monolayers, procoagulant activity, expression of 
adhesion molecules and intracellular oxidative stress (Fig. 7), (Hsieh et al., 2007). 
 
 
Figure 7. AGE/RAGE-mediated proinflammatory signaling and interventions. From: (Zong, 
Ward, & Stitt, 2011) 
 
In short, both hyperglycemia and glycation clinically are associated with diabetic 
complications, while LDL glycation is thought to play an important role in the 
pathogenesis of vascular and neurodegenerative diseases (Aronson & Rayfield, 2002; 
Basta, Schmidt, & De Caterina, 2004). 
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- Medicinal Plants 
 
Since very old times, herbal medications have been used for relief of symptoms of disease 
(Maqsood, Singh, Samoon, & Balange, 2010). The need for bioactive compounds with 
medicinal properties presents a tremendous challenge and has encouraged scientists to 
explore, in detail, plants that are potential sources of promising compounds (Holetz et al., 
2002; Novais et al., 2003). Despite the great advances observed in modern medicine in 
recent decades, plants still make an important contribution to health care. Much interest in 
medicinal plants emanates from their use in folk medicines as well for their prophylactic 
properties, especially in developing countries. A large number of medicinal plants have 
been investigated for their antioxidant properties, either in the form of raw extracts or of 
their chemical constituents, which may be effective to prevent the destructive processes 
caused by oxidative stress (Zengin, Aktumsek, Guler, Cakmak, & Yildiztugay, 2011). 
Although the toxicity profile of most medicinal plants has not been thoroughly evaluated, 
it is generally accepted that medicines derived from plant products are safer than their 
synthetic counterparts (Vongtau et al., 2005; y Tejidos, Sobre el Ciclo Estral, 2007). 
Furthermore, natural plant extracts and purified constituents have been evaluated for their 
role in preventing the formation of AGEs. So far, phenolic antioxidants have been found 
to be the most promising agents, and their activities against AGE formation in vitro have 
been shown, with a few exceptions, to correlate highly with their free radical scavenging 
activities. However, several clinical trials have failed to provide conclusive evidence for 
the efficacy of natural antioxidant therapy in diabetic patients. Therefore, it would be of 
great interest discovering natural AGE inhibitors that can suppress the formation of 
AGEs, both through preventing glycoxidation (scavenging free radical and/or chelating 
metal ions) and by sequestering reactive carbonyl species (especially 1,2-dicarbonyls, the 
key intermediates in the glycation of proteins). So far, very few natural products have 
been found to have scavenging activities against the reactive carbonyl species (RCS) 
(Peng et al., 2008).  
Therefore, the aim of this research was to investigate the antioxidant and antiglycation 
activities of selected medicinal plants by means of several experimental methods in vitro 
and ex vivo to outline their role in the prevention and/or treatment of cardiovascular 
diseases related to oxidative stress.  
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 Croton lechleri Muell.-Arg 
 
Croton lechleri (Euphorbiaceae) is a tree which grows in the low mountainous areas of 
the Peruvian Andean region, as well as in Colombia, Ecuador and Bolivia and it is known 
for its medicinal properties. The bark, when slashed, releases a red latex called “sangre de 
drago” or “sangre de grado” or “dragon’s blood” (Fig. 8). The blood-red latex (sap) is a 
common household remedy in Peru and in other Latin American countries, where 
indigenous tribes use the sap internally and externally to stop bleeding, help heal wounds, 
and treat intestinal ailments. 
In vitro and in vivo studies support the traditional use the viscous latex, which exhibits 
antioxidant, antiviral and anti-inflammatory activities, in addition to being efficacious in 
the treatment of different types of diarrhea, including cholera. The oral administration of 
a preparation, termed SP-303, isolated from the bark latex by Ubillas et al. (Ubillas et al., 
1994), leads to positive results in the treatment of traveler’s diarrheas and diarrheal 
episodes in AIDS patients and was approved as Crofelemer (Fulyzaq®) by the FDA in 
December 2012 to treat diarrhea in HIV/AIDS patients on antiretroviral therapy (Yeo, 
Crutchley, Cottreau, Tucker, & Garey, 2013). Crofelemer is an oligomeric 
proanthocyanidin mixture primarily composed of (+)-catechin, (-)-epicatechin, (+)-
gallocatechin, and (-)-epigallocatechin monomer units linked in random sequence 
(Tradtrantip, Namkung, & Verkman, 2010). When applied to the skin for treating 
abrasions and blisters, the red sap forms a seal, protecting the lesion. Thus, it is applied 
topically to reduce the symptoms of insect bites with a reduction of swelling and redness. 
The sap has been used in the treatment of several types of tumors. Since free radicals may 
participate in the early stages of carcinogenesis, recently antioxidant activity was 
evaluated against the oxidative damages induced by apomorfine in Saccaromices 
cerevisiae (De Marino et al., 2008). 
The sap derived by C. lechleri and related Croton species has been thoroughly 
investigated, both in terms of phytochemical profile and bioactivity, disclosing a unique 
phytocomplex characterized by peculiar lignans, proanthocyanidins, flavonols, steroids, 
and alkaloids. The characteristic secondary metabolites are proanthocyanidins, which 
account for up to 90% of dry weight and many polyphenolic components such as 
catechin, epicatechin, gallocatechin, epigallocatechin and dimeric procyanidins B-1 and 
B-4. Several minor constituents were also identified: clerodane diterpenoids such as 
korberin A and B, bincatriol, crolechinol, crolechinic acid and the dihydrobenzofuran 
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lignan 3’,4-O-dimethylcedrusin. Work on Croton lechleri led to the isolation of a 
benzylisoquinoline-like alkaloid taspine in the sap and thaliporphine and glaucine in the 
leaves. Taspine and the lignan 3’,4-O-dimethylcedrusin are thought to be responsible for 
the wound healing actions of sangre de drago, because of their stimulatory actions on 
wound repair (De Marino et al., 2008; D. Gupta, Bleakley, & Gupta, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Casimiroa spp. 
Casimiroa edulis Llave et Lex (Rutaceae) (Fig. 9) popularly called “Zapote blanco”, is a 
tree distributed in the temperate zones of Mexico and central America. The use of the tree 
in folk medicine is known from prehistoric times, where concoctions of the leaves or 
seeds are taken for their interesting sedative-like and sleep inducing effects. Furthermore, 
the seeds are also known to be used in the treatment of dermatological conditions 
(Romero, Escobar, Lozoya, & Enriquez, 1983). 
Most of the studies have been performed on the seeds, bark and fruits of Casimiroa 
edulis, and afforded a number of alkaloids, coumarins, flavonoids, zapotin, 3,5-
trimethoxyflavone and limonoids (Awaad et al., 2012). 
In pharmacological studies on Casimiroa edulis, alcohol extracts of seeds and aqueous 
extracts of leaves were found to have hypnotic, anticonvulsant and antihypertensive 
Figure 8. The Croton lechleri tree and the latex 
derived from the incision of its bark. From: 
http://ccbolgroup.com/sangreE.html and 
http://www.inriodulce.com/links/medicinalplants.ht
ml 
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effects (Magos & Vidrio, 1991). There have been many other pharmacological activities 
reported for samples of the plant taken from Mexico and America.  
Regarding, Casimiroa pubescens Ramirez, popularly known as rat sapote or bighorn 
sapote, is also used as a sedative, but unlike Casimiroa edulis, few chemical and 
pharmacological investigations were done to support its use against depression or anxiety 
(Suárez, 2012). 
 
 
 
 
 
 Ribes nigrum L. 
The genus Ribes belongs to the family of Grossulariaceae and has about 150 different 
species. Ribes nigrum (Fig. 10), known as Black Currant, is a perennial small shrub, 
which is widely distributed in Europe and North Asia, and is cultivated in many countries 
for its usage of the fruits in the food industry (Sasaki et al., 2013).  
The fruit of the black currant, black currant berries, are favored for their organoleptic 
properties such as distinctive color and intense flavor, which is due to phenolic 
compounds such as anthocyanins, and the presence of sugars, acids, and volatile 
compounds. Black currants are primarily cultivated for juice and beverage production and 
also processed for jams, jellies, purées, teas, as functional food products, and to some 
Figure 9. The tree, fruits and seed of Casimiroa edulis. From: 
http://www.phoenixtropicals.com/whiteSapote.html 
http://www.fairchildgarden.org/Articles/id/566/read/White-Sapote-Unique-and-Delicious/  
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extent, it is consumed fresh. The berries have significant antioxidant activity in part 
attributed to their relatively high content of ascorbic acid (vitamin C).The content of 
ascorbic acid in commercial cultivars ranges from 130–200 mg/100 mL fresh juice, but 
even higher levels (over 350 mg/100 mL) have been detected in some breeding materials. 
However, the antioxidant activity is also attributed to the high levels of phenolic 
compounds. The most important compounds are the anthocyanins, with an average 
content of approximately 250 mg /100 g in fresh fruits. In addition to anthocyanins, black 
currants also contain significant amounts of hydroxycinnamic acids, flavan-3-ols and 
flavonols, with potential health-promoting properties. There is convincing evidence about 
the positive contribution of black currant on human health, including effects on vascular 
function. Due to its health-promoting properties, black currants could be an important 
fruit in the daily diet. (Vagiri et al., 2013). 
The leaves of R. nigrum have been used as a traditional medicine for treatment of 
rheumatic disease in Europe, and have been shown to exhibit antioxidant and anti-
inflammatory effects. (Garbacki, Tits, Angenot, & Damas, 2004)  
The most important industrial product of black currant is berries; however, leaves and 
buds due to their characteristic color and excellent flavor have also found some 
applications as a raw material for the food and cosmetic industries. The information on 
antioxidant properties of black currant buds is rather scarce. Recently it was reported that 
buds (opened at the end of March) and leaves (in June) had a higher content in phenolics 
and antioxidants than fully ripened berries (in July) (Tabart, Kevers, Pincemail, 
Defraigne, & Dommes, 2006). 
 
 
                                                
Figure 10. Ribes nigrum fruits and leaves (left) 
buds (up). From: 
http://apps.rhs.org.uk/advice/ACEImages/RHS_SCN
0000766_330804.jpg and 
http://upload.wikimedia.org/wikipedia/commons/a/a
8/Schwarzejohannisbeere.jpg 
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 Boswellia serrata Roxb ex Colebr 
The gum resin of Boswellia serrata (Burseraceae), a kind of deciduous tree grown in the 
dry part of China and India, has been considered throughout the ages to have a wealth of 
healing properties and which has long been used, as reported in ancient Ayurvedic 
medical texts, as a powerful anti-inflammatory agent (I. Gupta et al., 1997). In fact, 
Boswellia serrata resins (Fig. 11) have been used for the treatment of rheumatoid arthritis 
and other inflammatory diseases such as Crohn’s disease. In pharmacological studies, the 
anti-inflammatory activity has been attributed to its ability in regulating immune cytokine 
production and leukocyte infiltration. Extracts from Boswellia serrata have been shown 
to possess anti-bacterial, anti-fungal, anti-carcinogenic, and anti-neoplastic properties. 
Clinically, this resin has been shown to reduce the peritumoral edema in glioblastoma 
patients and reverse multiple brain metastases in breast cancer patients. Also, efficacy, 
safety and tolerability profile of essential oil formulation containing Boswellia serrata oil 
has been confirmed for the treatment of acute soft tissue injuries (AHMED, ABDEL-
RAHMAN, SALEM, SHALBY, & LOKMAN, 2013). The pharmacological effects of 
Boswellia serrata gum resin extract are mainly attributed to boswellic acids (BAs), which 
were proposed to act as inhibitors of 5-lipoxygenase, nuclear factor kappa-B (NFκB)-
pathway, human leukocyte elastase, cathepsin G, and microsomal prostaglandin E2 
synthase (mPGES)-1. Several pilot clinical trials investigating the efficacy of BSE in the 
treatment of inflammatory disorders like Crohn's disease, ulcerative colitis, inflammatory 
bowel disease, rheumatoid arthritis, osteoarthritis, and asthma as well as phase I toxicity 
studies suggest promising beneficial therapeutic effects with no serious, long-term or 
irreversible adverse effects. Moreover, BSE was assigned the orphan drug status for the 
reduction of peritumoral edema by the EMA agency, in 2002 (Gerbeth et al., 2013).  
 
 
Figure 11. Boswellia serrata gum resin. 
From:http://www.greenclays.com/organic-
boswellia-serrata.php 
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AIM OF THE STUDY 
 
Many natural products have been reported to contain large amounts of antioxidants other 
than the well-known vitamin C, E and carotenoids. These antioxidants play a benefic role 
in delaying, intercepting, and preventing oxidative reactions which if not controlled are 
mostly undesirable. Interesting is the discovery of natural antioxidants of plant origin. 
The aim of this study was to assess the antioxidant activity of some selected traditionally 
used medicinal plants. 
The plant extracts assessed in this study are: Ce1, methanolic seed extract of Casimiroa 
edulis; Ce2, aqueous leaf extract of Casimiroa edulis, Cp1, methanolic seed extract of 
Casimiroa pubescens, Cp2, methanolic leaf extract of Casimiroa pubescens; SdD, dry 
residue obtained by lyophilisation of Croton lechleri sap; Rn, hydroalcoholic bud extract 
of Ribes nigrum; and Bs, oleo-gum extract of Boswellia serrata. 
In previous studies of our laboratory, we focused on phytochemical characterization and 
vasorelaxation of coumarin compounds from Casimiroa genus and their extracts (Bertin, 
Chen et al. 2013, Bertin, Garcia-Argaéz et al. 2011, Froldi, Bertin et al. 2011), on 
phytochemical characterization and studies on the in vitro vascular modulation and 
antiproliferative activities of Croton lechleri sap (Montopoli, Bertin et al. 2012, Bolcato 
Jenny 2010), on chemical characterization and in vitro study of anti-inflammatory activity 
of Boswellia serrata (Rancan Serena 2013). Further, it was observed that in literature the 
studies on the antioxidant activity on these plant extracts are mostly incomplete. Thus, the 
present study was designed to evaluate these plant extracts for the antioxidant capacity 
with different in vitro and ex vivo assays, based on different scavenging mechanisms to 
obtain a complete antioxidant profile. 
The following steps were applied: 
 Determination in vitro antioxidant activity using DPPH· assay (based on SET 
mechanism) and ORAC assay (based on HAT mechanism);  
 Assessment of several statistical programs for EC50 estimation in DPPH· assay; 
 Determination non-enzymatic antioxidant content by measuring the total 
polyphenolic content (TPC) and total flavonoid content (TFC); 
 Determination ex vivo antioxidant activity to evaluate inhibitory effect on LDL 
peroxidation using TBARS test and determination of conjugated dienes; 
 In vitro study of anti-glycation activity based on BSA-glucose/ribose model. 
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MATERIALS AND METHODS 
 
- Chemicals and solutions 
AAPH 2,2'-Azobis(2-amidinopropane) dihydrochloride 98% (Acros Ognanics) 
C8H18N6 · 2HCl (PM = 271.19 g/mol)  
AlCl3 (Sigma-Aldrich) (PM = 133.34 g/mol) 
Aminoguanidine-bicarbonate 97% (Sigma-Aldrich) NH2NHC(=NH)NH2 · H2CO3 (PM 
= 136.11 g/mol) 
BHT Butylated hydroxytoluene (Sigma-Aldrich); C15H24O (PM = 220.35 g/mol) 
BSA Albumine Bovine fraction V lyophilized powder ( Sigma-Aldrich) (PM ~ 68.000 
g/mol) 
CuSO4·5H2O Copper(II) sulfate pentahydrate (Sigma-Aldrich) (PM = 249.69 g/mol) 
D(+)-Glucose Anhydrous (J.T.Baker) C6H12O6 (PM = 180.16 g/mol) 
DMSO Dimethyl sulfoxide 99.9% (Carlo Erba) 
DPPH· 2,2-difenil-1-picrilidrazile (Sigma-Aldrich) C18H12N5O6 (PM = 394.32 g/mol) 
D(-)-Ribose (Sigma-Aldrich) C5H10O5 (PM = 150.13 g/mol) 
Folin-Ciocalteu's phenol reagent (Merck) 
Fuorescein free acid (Sigma-Aldrich) C20H12O5 (PM = 332.31 g/mol)   
Gallic acid monohydrate (Sigma-Aldrich) (HO)3C6H2CO2H · H2O (PM = 188.13 g/mol) 
Methanol (HPLC grade) (Sigma-Aldrich) 
Na2-EDTA Ethylenediaminetetraacetic acid disodium salt dihydrate (Sigma-Aldrich); 
C10H14N2Na2O8 · 2H2O (PM = 372.24 g/mol) 
PBS Phosphate buffered saline (ex vivo experiments) NaCl 137 mM; KCl 2.7 mM; 
Na2HPO4 
. 
2H2O 10 mM; KH2PO4 2 mM, pH 7.4 
PBS Phosphate buffered saline (in vitro experiments)  NaH2PO4 
.
 2H2O 41.25 mM; 
Na2HPO4
.
 2H2O 54.23 mM, pH 7.4 
Quercetin dihydrate (Sigma-Aldrich) C15H10O7 · 2H2O (PM=338.27 g/mol) 
TBA 2-thiobarbituric acid (Sigma-Aldrich); C4H4N2O2S (PM = 144.15 g/mol) 
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TCA  trichloroacetic acid (Merck); CCl3COOH (PM = 163.39 g/mol) 
Trolox
®
 (±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid 97% (Sigma-
Aldrich) C14H18O4 (PM = 250.29 g/mol) 
- Plant materials 
All the extracts of Casimiroa spp. have been given from colleagues of Instituto de 
Química, Univesidad Nacional Autónoma de México, Circuito Exterior, Ciudad 
Universitaria, Coyoacán 04510, México D.F. 
Ce1, methanolic seed extract of Casimiroa edulis  
Ce2, aqueose leaf extract of Casimiroa edulis 
Cp1, methanolic seed extract of Casimiroa pubescens 
Cp2, methanolic leaf extract of Casimiroa pubescens 
SdD dry residue obtained by lyophilisation of Croton lechleri sap, collected through 
incision of the bark from trees growing in the province of Napo, Ecuador. The voucher 
code number (SdD 007) for the crude drug was deposited in the Department of 
Pharmaceutical and Pharmacological Sciences of Padua University. 
Rn 2% hydroalcoholic solution of the extract of the buds of Ribes nigrum (Cento Fiori srl 
Forlì).  
Bs oleo-gum extract (EPO, Milano Italy). 
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In vitro methods 
 
- DPPH· assay 
DPPH· (2,2-diphenyl-1-picrylhydrazyl) is a stable free-radical compound that appears as 
a dark-colored crystalline powder (Fig. 12).  
 
  
 
 
 
Figure 12. Chemical structure of DPPH·. 
 
The delocalisation of  the spare electron over the molecule DPPH· gives rise to the deep 
violet colour, characterised by an absorption band in methanol solution centred at about 
520 nm, Figure 13. When a solution of DPPH• is mixed with a substance that can donate 
a hydrogen atom or an electron gives rise to the reduced form with the loss of the violet 
colour, with a residual pale yellow colour due to the picryl group still present (Molyneux, 
2004).  
 
 
 
 
 
 
 
 
 
Figure 13. DPPH· radical has a deep violet color in methanolic solution, 
and it becomes colorless or pale yellow when reduced. From: 
http://en.wikipedia.org/wiki/DPPH 
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Thus, when a solution of DPPH· is placed in contact with a substrate electron donor or 
hydrogen it passes to a stable  no-radical form, with a change of the color of the solution 
to pale yellow, and the extent of discoloration is proportional to the scavenging activity 
against the DPPH· radical. This, it can be monitored by spectrophotometric analysis at a 
wavelength of 517 nm.  
The analysis is simple, sensitive and fairly rapid and needs only a UV–Vis 
spectrophotometer, this explains its widespread use in antioxidant screening. The results 
are normally expressed using the EC50 value, defined as the concentration of antioxidant 
that causes a 50% decrease in the DPPH absorbance. 
- Experimental Protocol: 
The DPPH· radical scavenging assay was performed according to the method reported by 
(Brand-Williams, Cuvelier, & Berset, 1995) with some modifications. 
At the beginning, it was prepared a methanol solution of 70 µM DPPH• kept in an amber 
glass bottle with screw cap. At the same time, the solutions of the extracts were prepared 
from stock solutions. The DPPH• methanolic solution was subdivided in amber vials, and 
then the samples were added to obtain the final concentrations, within a range from 0.1 to 
1000 µg/ml.  
The vials were shaken vigorously, incubated for 60 minutes in the dark, at room 
temperature. After incubation, the samples were read by a spectrophotometer (λ = 517 
nm). The control solution was done with DPPH• supplemented with methanol instead of 
sample solution. In this determination were used quartz cuvettes with a cross section of 
10 mm and a spectrophotometer Beckman Coulter model DU 800. 
The DPPH· scavenging effect was calculated using the following equation: 
 
 
A0 is the absorbance of control solution, A is the absorbance of the solution of DPPH• 
treated with the plant sample, and Ab is the absorbance of the methanolic solution of the 
sample, this procedure allows to eliminate any interference of solvent absorbance on 
spectrophotometric determination.  
All solutions were prepared daily and stored at room temperature, protected from light. 
After the spectrophotometric reading, the antioxidant efficacy was determined using the 
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EC50 value, using appropriate software (Chen, Bertin, & Froldi, 2013). Several 
experimental evidences have indicated a non-linear relationship between the antioxidant 
concentration and the DPPH· radical scavenging activity (Eklund et al., 2005; Villaño, 
Fernández-Pachón, Troncoso, & García-Parrilla, 2005); as a consequence, the 
determination of EC50 becomes quite problematic, revealing a variable goodness of fit for 
the plotted regression models. So it was performed a comparison study to identify the 
more suitable program for the EC50 estimation from experimental data obtained by DPPH
 assay by comparing various statistical programs. For this, six computational programs 
and four different regression models  were employed to estimate the EC50 value, using 
various standard natural antioxidants (Tab. 2).  
 
Table 2: The statistical programs used in the comparative study 
 
Statistical program Equation for EC50 calculation Note 
GraphPad Prism 5.01(4P) 
 
Y: response; x: 
concentration of the 
agonist; bottom: baseline; 
top: maximum response; 
Hillslope: steepness of the 
antiradical curve. xb: 
concentration of the 
sample at the inflection 
point; s: asymmetry of the 
curve. 
GraphPad Prism 5.01(5P) 
  
 
BLeSq 0.9.1 
 
y = ln (p/1 − p) p: probability 
OriginPro 8.5 
  
A1: baseline; A2: 
maximum response; p: 
slope of the curve; x0 
concentration at the 
inflection point, EC50 
value. 
SigmaPlot 12 
  
x0: concentration at the 
inflection point; c: 
asymmetry factor; b: 
slope; Y0 and a: min and 
max of Y values. 
BioDataFit 1.02 
  
A1: baseline; A2: 
maximum response; p: 
slope of the curve; x0 
concentration at the 
inflection point, EC50 
value. 
IBM SPSS Statistics 
Desktop19.0 
Relative function for EC50 calculation, equation not available  
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To this purpose six standard compounds were used: quercetin, (+)-catechin, l-ascorbic 
acid, caffeic acid, chlorogenic acid, and N-acetyl-cysteine. Each compound was assayed 
at eight different concentrations, within the range of 0.1–300 μmol/l, and then the 
experimental data were processed by six different statistical programs to obtain estimated 
EC50 values. However, these ones may be considered as theoretical values, because they 
are derived from a range of antioxidant concentrations, where experimental points are 
rather far from the actual EC50 value. For this reason, in order to determine the most 
reliable EC50 value, successively the DPPH  scavenging assay was still performed for 
each antioxidant using several concentrations closer to the estimated EC50. The evaluation 
of the antiradical curve done in a smaller range of antioxidant concentrations, as near as 
possible to the estimated EC50 value, enables a more accurate specification of the EC50 for 
the mathematical interpretation. For this, to perform a more accurate analysis, we 
enclosed the EC50 value within a narrow range. Once the EC50 fell in a narrow range, it 
may be calculated by using a simple mathematical method based on the principle of right-
angled triangle (Alexander, Reading, & Benjamin, 1999). This method was applied to all 
the antioxidant compounds to obtain the actual EC50 values (Fig. 14).  
 
Figure 14. The  EC50 derivation from the concentration–response curve of catechin, obtained by 
GraphPad Prism five-parameter regression, with highlighted the nearest actually recorded 
responses (A and B) of each experimental concentration (C and D); on either side of the EC50 
forming a right-angled triangle, according the method of (Alexander et al., 1999). 
 
To apply this method, two assumptions have to be accepted: (1) that the maximum 
response is reached, and (2) that the responses to the experimental concentrations of the 
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two recorded points on either side of the 50% response should be as close as possible to 
the point of the EC50, in order to consider the sigmoid curve as a straight line. As shown 
in FigureY, Δα and Δβ are two similar triangles, where the corresponding sides have 
lengths in the same ratio. A, B, C, and D are known values from the experimental data; 
since we have already normalised the data in percentage, the EC50 response is the 50% of 
the maximal response. Therefore, we applied the follow equation (Alexander et al., 1999): 
 
 
 
We estimated the goodness of the regression for the programs, adopting the following 
equation: 
 
where μ is the actual EC50, N is the number of reference compounds (i.e. 6) and xi is the 
estimated EC50 value for each antioxidant.  The program that has showed the lowest 
variance was considered as the best statistical program tested. 
 
- ORAC assay 
The oxygen radical absorbance capacity (ORAC) assay is a widely used method to 
characterize the antioxidant capacity of different materials such as biological fluids, 
essential oils, spices, foods, dietary supplements, or cosmetic products. 
In this assay, a peroxyl radical reacts with a fluorescent probe to form a nonfluorescent 
product; therefore, the reaction can be easily quantified by fluorescence. The peroxyl 
radical used is 2,2′-azobis(2-amidinepro-pane) dihydrochloride (AAPH), which reacts 
with fluorescein (3′,6′-dihydroxyspiro[isobenzofuran-1[3H],9′[9H]-xanthen]-3-one) that 
is the fluorescent probe. The ORAC reaction is performed at 37°C, and since it is 
temperature sensitive,  this  is strictly-controlled throughout all the experiment. 
The ORAC assay depends on the free radical damage to a fluorescent probe that 
correlates with a decrease of the fluorescence intensity; this is an index of the degree of 
free radical damage. In the presence of an antioxidant, there will be an inhibition of free 
radical damage, with a protection of the probe fluorescence, Fig. 15. The uniqueness of 
the ORAC assay is that the reaction is driven to completion and the quantitation is 
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achieved using “area under the curve” (AUC). In particular, the AUC method allows 
ORAC to determine both inhibition time and inhibition percentage of the free radical 
damage into a single value (Fig. 16). 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.  Schematic illustration of the principle of the ORAC assay. From: (Huang, Ou, 
Hampsch-Woodill, Flanagan, & Prior, 2002) 
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Figure 16.  Illustration of calculation of the ORAC value expressed as the net area under the 
curve (AUC). From: (Huang et al., 2002) 
 
 
The net area under the curve (AUC) of the standards and samples was calculated. The 
standard curve is obtained by plotting Trolox
®
 concentrations against the net AUC of the 
measurements for each concentration. Final ORAC values are calculated using the 
regression equation between Trolox
®
 concentration and the net AUC and are expressed as 
micromole Trolox
® 
equivalents per liter for liquid samples or per gram for solid samples. 
The AUC is calculated as: 
 
                                 AUC = 0.5 + f1/f0 + ... fi/f0 + f59/f0 + 0.5(f60/f0)  
 
where f0 is the initial fluorescence reading at 0 min and fi  is the fluorescence reading at 
time i. 
The net AUC is obtained by subtracting the AUC of the blank from that of a sample. 
ORAC values are usually reported as Trolox equivalents. 
 
- Experimental protocol 
 
ORAC assays were performed as described by (Gillespie, Chae, & Ainsworth, 2007) with 
some modifications. Briefly, prepare the sample solution and the solution of fluorescein 
in PBS to a final concentration of 0.08 µM, kept on ice and protected from light. 
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At the same time prepare the solutions of standard antioxidant (Trolox
®
) and the 
generator of peroxy radicals (AAPH). Trolox is solubilized in PBS so as to obtain a 10
-4
 
M stock solution, from which it is prepared by progressive dilution solutions of 50 µM , 
25 µM, 12.5 µM and 6.25 µM. The AAPH solution was prepared in PBS at a 
concentration 0.15 M, all solutions must be prepared freshly and kept on ice and protected 
from light. Then we set the microplate reader (VictorTM X3, PerkinElmer) for a kinetic 
reading of fluorescence at 37 °C for one hour, with the wavelength of excitation at 485 
nm and emission at 530 nm, preheating the instrument to 37 °C for 10 min. In a 24-well 
plate were added 1500 µL of fluorescein solution 0.08 µM , 250 µL of buffer solution or 
standard solution of Trolox
®
 (6.25 - 50 µM) or sample solution, then add 250 µL of 
AAPH solution in each well and proceed directly to the fluorescence reading through 
regular scans at intervals of one minute to 60 minutes total. 
Once obtained the decay curves of the fluorescence signal, calculate the AUC relative to 
each well by subtracting the average value of the AUC of the blank from the AUC of 
Trolox
® 
and the test sample. It was obtained in this way, the net AUC and, through it, the 
calibration line and the corresponding equation to obtain the final value expressed in 
TEAC (Trolox equivalent antioxidant capacity).  
 
- Determination of the Total Phenolic Content (TPC)  
 
The TPC assay relies on the transfer of electrons in alkaline medium from phenolic 
compounds to phosphomolybdic/phosphotungstic acid complexes to form blue complexes 
that are determined spectroscopically at 760 nm with Beckman Coulter model DU 800. 
Although the exact chemical nature of the reaction is unknown, it is believed that 
sequences of reversible one- or two-electron reduction reactions lead to blue species 
(possibly, PMoW11O40). The total phenolic content of the extracts was determined using 
the Folin-Ciocalteu reagent (V. Singleton & Rossi, 1965). The reaction mixture contained 
50 μl of diluted vegetable extract, 4.2 ml of freshly prepared diluted Folin-Ciocalteu 
reagent, and 750 μl of 22% sodium carbonate. The mixtures were kept in dark, at ambient 
conditions, for 2 h to complete the reaction. Then, the absorbance at 760 nm was 
measured. A standard curve with five concentrations of gallic acid standard solution (0 
µg/ml, 50 µg/ml, 100 µg/ml, 150 µg/ml, 250 µg/ml and 500 µg/ml) was generated. The 
TPC of each extract is expressed as milligrams of gallic acid equivalents (GAE) per g of 
extract. 
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- Determination of Total Flavonoid Content (TFC) 
 
This method for the quantification of flavonoids is based on the spectrophotometric 
determination of a complex flavonoid-AlCl3, which provides a bathochromic 
displacement and the hyperchromic effect. 
The principle of aluminium chloride colorimetric method is that aluminium chloride 
forms acid stable complexes with the C-4 keto group and either the C-3 or C-5 hydroxyl 
group of flavones and flavonols. In addition, aluminium chloride forms acid labile 
complexes with the orthodihydroxyl groups in the A- or B-ring of flavonoids. Thus, the 
total flavonoid content of the plant extracts was estimated by aluminium chloride (AlCl3) 
colorimetric method (Fernandes, Ferreira, Randau, de Souza, & Soares, 2012).  
The extracts were diluted with methanol to 5 mg/ml. Briefly, 200 µl AlCl3 2.5% (w/v) 
was added to 400 µl of each diluted solution and the solution were made up to 2.5 ml by 
adding 1.9 ml of distillate water. After 15 min of incubation at room temperature, the 
absorbance was measured by spectrophotometer Beckman Coulter model DU 800 at 410 
nm. The same procedure was repeated without the addition of AlCl3 for preparation of the 
contrast solution. The standard curve of known concentrations of quercetin was generated 
by preparing and testing five concentrations of quercetin standard solution, which were 
0.0 µg/ml, 12.5 µg/ml, 25µg/ml, 500 µg/ml, 1000 µg/ml. Total flavonoid content (TFC) 
was expressed as milligrams of quercetin equivalents per g of extract.  
 
 
Ex vivo methods 
 
- Thiobarbituric Acid Reactive Substances (TBARS) test 
 
The TBARS test is the most common method for measuring malondialdehyde (MDA) in 
food products and biological samples. MDA is a major degradation product of lipid 
hydroperoxides, Fig. 17. TBARS test is based on spectrophotometric quantitation of the 
pink complex formed after reaction of MDA with two molecules of thiobarbituric acid 
(TBA)(Fig. 18). This method was used to determine the human LDL oxidation ex vivo. 
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Figure 17. The two mechanisms proposed by (Esterbauer, Schaur, & Zollner, 1991) and 
colleagues (1991) based on the successive hydroperoxide formation and β-cleavage of the 
fatty acid chain to give a hydroperoxyaldehyde; MDA is then generated by β-scission or by 
reaction of the final acrolein radical with a hydroxyl radical. 
 
 
 
 
 
 
 
 
 
 
Figure 18. Chromophore formed by condensation of MDA with TBA. From: (Botsoglou et al., 
1994) 
 
- Experimental protocol 
After carrying out an exhaustive dialysis of human LDL in EDTA–free PBS, transfer 480 
µL of the LDL suspension (25 µg/mL) in each of the six microtubes with safety lock 
(Eppendorf Safe-Lock Tubes 2.0 mL), and then add 24 µL of diluted methanolic solution 
of the sample and incubate for about 15 minutes. Then add 12 µl of aqueous solution of 
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0.4 mM CuSO4, obtaining a final concentration of 10 µM in the reaction mix. Close the 
microtubes and keep them in a water bath for 1 hour at 37 °C, to facilitate the process of 
oxidation on LDL. After incubation, the microtubes were transferred on ice, 50 µL of an 
aqueous solution of Na2-EDTA was added to chelate the CuSO4 and stop the oxidation 
process. Then proceed with the addition of butylated hydroxytoluene (BHT, 25 µl, 2 g/L), 
250 µL of trichloroacetic acid (TCA, 100 g/L and 500 µL of TBA 6.7 g/L; BHT is an 
alkylated phenol antioxidant action, while the TCA is used to acidify the reaction 
environment and promote the binding of TBA with malondialdehyde produced during 
peroxidative degradation of LDL. The microtubes were filled with N2 gas and stirred 
gently, then moved into boiling water for 20 minutes. After this period, in which is 
formed the adduct MDA-TBA2, the microtubes were transferred on ice and centrifuged at 
3000 g for 5 minutes. The supernatant was transferred in quartz cuvettes for 
spectrophotometric reading, at a wavelength of 532 nm with Beckman Coulter model DU 
800.  
The absorbance is converted into equivalent of MDA using its molar extinction 
coefficient ε 
 
εMDA = 1.56 X 105 M-1 cm-1 
 
Thus for the Beer -Lambert law lcε=A  , it can be obtain  the concentration c of MDA : 
 
 
 
 
- Determination of Conjugated Dienes  
 
The primary products of lipid peroxidation are hydroperoxides of the general structure: -
CH=CH-CH=CH-CHOOH-, with an absorption maximum around 234 nm. Since ox-LDL 
is, like native LDL, fully soluble in buffer, the generation of such conjugated lipid 
hydroperoxides can directly be measured by recording the UV spectrum of the aqueous 
LDL solution. An example for such an experiment is shown in Figure 18. The kinetic of 
the diene formation, i.e. the change of the absorbance vs. time, can be clearly divided into 
three phases (Fig. 19). A first phase, during which the dienes very slowly increase, a 
5101,56 
A
=
lε
A
=c
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second phase during which they very rapidly increase to a maximum value, and at the 
end, a third phase during which the dienes decrease. The first two phases can be termed as 
lag-phase and propagation phase. During the lag-phase, the endogenous lipophilic 
antioxidants of LDL protect the polyunsaturated fatty acids against oxidation, and thus 
prevent that the lipid peroxidation process may come into the rapid propagating chain 
phase. The protective action of the antioxidants progressively decreases since they are 
inactivated and consumed in free radical scavenging. When the LDL particle is depleted 
of its antioxidants, the lipid peroxidation process enters in the propagation phase in which 
the polyunsaturated fatty acids are rapidly converted to conjugated lipid hydroperoxides, 
as indicated by the increase of the 234 nm absorbance. The transition from the lag-phase 
to the propagation phase is not abrupt, but a continuous process.  We define the end of the 
lag-phase as the interval (minutes) between the intercept of the linear least-square slope 
of the curve with the initial-absorbance axis as shown in Figure 18. The last phase of the 
LDL oxidation is characterized by decomposition of the lipid hydroperoxides formed 
during the propagation phase. These decomposition reactions are extremely complex and 
can lead to many compounds showing UV absorbance in the 210-240 nm range; for 
example, 2-alkenals or 4-hydroxyalkenals, typical products of lipid peroxidation, absorb 
at 220-225 nm region (Esterbauer, Striegl, Puhl, & Rotheneder, 1989). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. The three phases of LDL oxidation: lag phase, propagation phase, and 
decomposition phase. From: (Scheffer, Teerlink, & Heine, 2005) 
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- Experimental protocol 
 
After carrying out an exhaustive dialysis of human LDL in EDTA-free PBS, transfer 480 
µL of suspension of LDL (25 µg/mL) in each of the six microtubes, then add 24 µL of 
diluted methanolic solution of the sample and incubate the mixture for about 15 minutes. 
Then add 12 µL of aqueous solution of 0.4 mM CuSO4, to obtain a final concentration of 
10 µM in the reaction mixture. Transfer the contents of each microtube in a quartz cuvette 
and proceed to the kinetic reading with a spectrophotometer Beckman Coulter model DU 
800 at 234 nm and at 37 °C, performing scans at regular intervals of 5 minutes.  
 
- Determination of the Advanced Glycation Endproducts  
All proteins are subject to glycation reactions, and so far no exception has been reported. 
The glycation reaction between amine residues of protein with glucose is very rapid and 
initially reversible, producing a labile Schiff-base. The product may then react further, 
through an Amadori-rearrangement, to give a relatively stable fructosamine. This 
Amadori product is the characteristic product of glycated proteins. Finally, in long-living 
proteins, a cascade of slow cross-link reactions may result in advanced glycation end 
products (AGEs) (Fig. 20) (Sobal, Menzel, & Sinzinger, 2000).  
Therefore, glycation reactions are consist of two stages. In the first step, glucose and the 
amino groups of lysine residues react with each other to form fructose-lysine (FL). The 
subsequent processes are dehydration, rearrangements and cyclization. Later, further 
reactions result in the formation of advanced glycation end products AGEs (browning- or 
Maillard products), Figure 19. From these reactions, the main characterized products are 
carboxymethyl-lysine (CML) and pentosidine. CML can be formed by free radical 
cleavage of FL and pentosidine is a glucose-derived cross-link involving arginine and 
lysine residues. Most AGEs can easily be measured by fluorescence (excitation at 370 nm 
and emission at 440 nm) or by an ELISA technique using anti-AGE antibodies (Sobal et 
al., 2000). 
 
42 
 
 
                                                        
Figure 20. The formation of advanced glycation end products. 
From: http://www.liquida.it/louis-camille/ 
 
- Experimental protocol 
The methodology was based on that of (Perez,R M Perez Gutierrez, Rosa, 2012). BSA 
was incubated with glucose or ribose in phosphate buffered-saline (PBS) (pH 7.4) in the 
presence of extract at 37°C for 5 or 7 days. In each test solution there are: BSA (50 
mg/mL), glucose (0.8 M) or ribose (0.1 M), sample (5 to 100 µg/mL) and 0.02% sodium 
azide. 
All the reagents and samples were sterilized by filtration through 0.2 μm membrane 
filters. The protein, the sugar and the prospective inhibitor were included in the mixture 
simultaneously. Aminoguanidine (50 mM) was used as an inhibitor positive control. 
Reactions without any inhibitor were also setup. Each solution was kept in the dark in a 
capped tube. After 5 or 7 days of incubation, fluorescence intensity (excitation 
wavelength of 355 nm and emission wave-length of 460 nm) was measured for the test 
solutions. Percent inhibition was calculated as follows: 
 
                                         
 
where As = fluorescence of the incubated mixture with sample, Ac is the fluorescence of 
the incubated mixture without sample as a positive control, and Ab is the fluorescence of 
incubated mixture without sugar (blank control). 
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STATISTICAL ANALYSIS 
 
 
Results were expressed as means ± standard error of the mean (SEM) of at least three 
measurements. Statistical analysis was performed using Student’s t-test and P < 0.05 was 
considered to be significant. And in DPPH· assay, EC50 estimation was obtained by use 
of GraphPad Prism
®
 5P.  
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RESULTS 
 
In vitro methods 
DPPH· assays are usually classified as SET (Single Electron Transfer) reactions. These 
radical indicators may be neutralized by direct reduction via electron transfer or by 
radical quenching via hydrogen atom transfer (Prior et al., 2005). In general, SET-based 
assays measure antioxidant reductive capacity.  
The addition of the extracts to the DPPH solution induced a rapid decrease in its 
absorbance, determined at 517 nm. Fig. 21 shows the effect of different plant extracts in 
comparison with ascorbic acid on the inhibition of DPPH· radical. Our investigation 
shows that free radical scavenging ability of Croton lechleri was similar to ascorbic acid 
under the test conditions.  
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Figure 21 DPPH· assay: scavenging effects of the plant extracts determined using 
spectrophotometry. Each value is the mean ± SEM (n=5). 
 
 
The EC50, defined as the concentration of antioxidant that causes a 50% decrease in the 
DPPH·
 
absorbance, is generally used as an indicator of antioxidant capacity for plant 
extracts and pure compounds. Therefore, for each substance the EC50 value was 
determined using GraphPad Prism
®
 5P (Tab. 3), this to compare the antioxidant potency 
of all of the extracts (Chen et al., 2013).  
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Table 3 The antioxidant potency of the 
plant extracts determined by use of 
DPPH· assay. 
Extract EC50
*
 (µg/ml) 
SdD 2.74 
Ce2 33.17 
Cp2 41.72 
Rn 109.90 
Ascorbic acid 1.77 
* For the extracts which did not reach the 
50% inhibition it was not possible to 
obtain the EC50 value. 
 
Though the antioxidant potential of Croton lechleri was found to be slighter lower than 
that of ascorbic acid, anyway, the study revealed the prominent antioxidant activity of the 
sap (Table 3). Further, our investigation shows that the two Casimiroa leaf extracts have a 
good free radical scavenging activity. 
Before using GraphPad Prism
®
 5P as the statistical program of choice for EC50 
estimation, it was performed a comparative study to find the best statistical program to 
estimate EC50 values in DPPH· assay, using five statistical programs and six standard 
compounds. Estimated EC50 values by statistical programs are considered as theoretical 
values, while the actual EC50 values were determined by performing the same assay on a 
smaller range and using a simple mathematical method based on the principle of right-
angled triangle, see Materials and Methods (Tab. 4).   
 
 
Table 4. The EC50 values for standard antioxidants expressed as pD2 (-log EC50) ± SD, 
obtained after statistical elaboration with six softwares; in the last row, the actual EC50 values 
were obtained by applying the  right-angled triangle method (see methods). 
 Quercetin (+)-Catechin L-Asc. acid Caffeic acid Chlor. acid N-acetyl-cyst. 
GraphPad a 5.392 ± 0.046 5.130 ± 0.047 4.869 ± 0.032 5.007 ± 0.038 5.309 ± 0.035 4.466 ± 0.039 
GraphPad b 5.316 ± 0.046 5.109 ± 0.021 4.830 ± 0.058 4.993 ± 0.011 5.293 ± 0.023 4.578 ± 0.035 
Blesq c 5.272 ± 0.041 5.097 ± 0.054 4.851 ± 0.049 5.018 ± 0.051 5.246 ± 0.042 4.388 ± 0.050 
Blesq d 5.304 ± 0.076 5.000 ± 0.076 4.893 ± 0.039 5.018 ± 0.051 5.305 ± 0.035 4.496 ± 0.010 
BioDataFit 5.411 ± 0.030 5.166 ± 0.035 4.881 ± 0.023 4.992 ± 0.024 5.314 ± 0.016 4.576 ± 0.023 
OriginPro 5.411 ± 0.030 5.166 ± 0.035 4.881 ± 0.023 4.992 ± 0.024 5.314 ± 0.016 4.576 ± 0.023 
SigmaPlot 5.316 ± 0.046 5.109 ± 0.021 4.830 ± 0.058 4.993 ± 0.011 5.293 ± 0.023 4.578 ± 0.035 
SPSS 5.354 ± 0.212 5.159 ± 0.131 4.870 ± 0.136 5.023 ± 0.138 5.287 ± 0.125 4.440 ± 0.130 
Actual EC50 5.261 ± 0.021 5.095 ± 0.004 4.793 ± 0.006 4.930 ± 0.016 5.203 ± 0.008 4.521 ± 0.028 
a  GraphPad log (inhibitor) vs. normalized response model (variable slope). 
b  GraphPad five-parameter regression model. 
c  Blesq logit regression model. 
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d  Blesq logit regression model with outliers elimination. 
 
The relative variance of the estimated EC50 of each antioxidant was calculated for the 
different statistical programs; SigmaPlot and GraphPad Prism 5P implemented with a 
five-parameter equation showed the minor variance and seem to work with a better 
approximation in relation to actual EC50 values. Given that GraphPad Prism was almost 
exclusively developed for biological and pharmacological use, and GraphPad Prism 5P is 
the only that could easily load all datasets together and could plot them on the same 
graphic, with an automatic update after every data changing in the spreadsheet cells, we 
suggest the five-parameter regression model as an efficient statistical strategy for curve-
fitting, EC50 determination and data processing (Chen et al., 2013). 
 
ORAC (oxygen radical absorbance capacity) assay is based on HAT (Hydrogen Atom 
Transfer) mechanism, it measures the antioxidant inhibition of peroxyl radical induced 
oxidations, and thus reflects classical radical chain breaking antioxidant activity by H 
atom transfer (Ou, Hampsch-Woodill, & Prior, 2001). The results obtained in the ORAC 
assay are shown in Fig. 22,  and  summarized in Tab. 5.  
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Figure 22 The ORAC results for the extracts are expressed as micromole of 
Trolox equivalents per gram.  
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Table 5. The TEAC values of the extracts 
obtained by ORAC assay. 
Extract TEAC (µmol/g) 
SdD 5735 ± 261 
Cp2 1496 ± 171 
Ce2 1181 ± 102 
Cp1 479 ± 28 
Ce1 273 ± 54 
Bs 599 ± 73 
Rn 256 ± 21 
Each value in the table is represented as mean ± SEM (n = 5).  
                         
Using this antioxidant assay, the two Casimiroa leaf extracts (Ce2 Cp2) showed high 
ORAC values, and the Croton lechleri sap had higher activity.  
 
In order to obtain a deeper knowledge on the antioxidant capacity, the determination of 
total phenolic content and total flavonoid content were carried out in all the extracts 
considered in this research (Fig. 23). 
 
0 2 0 0 4 0 0 6 0 0 8 0 0 1 0 0 0
B s
R n
C p 2
C p 1
C e 2
C e 1
S d D
m g  G A E /g  e x tra c t
 
Figure 23 Total phenolic content (TPC) determined in the analyzed 
extracts, expressed as mg GAE (gallic acid equivalents)/g extract. 
Results are the means ± SEM of at least three experiments. 
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The TPC values were expressed as milligram gallic acid equivalents (GAE) per gram of 
dry extract. Ribes nigrum showed the highest amount of phenols equal to 921.04 ± 8.27 
mg GAE/ g of extract, followed by Croton lechleri which showed an amount of 713.76 ± 
32.22 mg GAE. The extracts of Casimiroa spp. showed a minor quantity of phenolic 
compounds including in a range from 50 to 200 mg GAE, while Boswellia serrata 
showed a negligible content. 
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Figure 24 Total Flavonoid Content (TFC) of the extracts are expressed as mg QE (quercetin 
equivalents)/g extract. Each value is reported as mean ± SEM of at least 3 experiments. Ce…..  
 
It is well known that various phenolic compounds cause different responses in this assay. 
The molar response of this method is roughly proportional to the number of phenolic 
hydroxyl groups in a given substrate, but the reducing capacity is enhanced when two 
phenolic hydroxyl groups are oriented ortho or para (Frankel, Waterhouse, & Teissedre, 
1995). Since these structural features of phenolic compounds are reportedly also 
responsible for antioxidant activity, measurements of phenols in these extracts  may be 
related to their antioxidant properties. 
Further, it was determined the total flavonoid content of each extract which was 
expressed as milligrams quercetin equivalents (QE) per gram of dry extract (Fig.24). The 
two Casimiroa leaf extracts showed highest flavonoid content equal to 29.92 ± 3.07 mg 
QE/g extract (Cp2) and 16.98 ± 0.53 mg QE/g extract (Ce2), respectively. A lower level 
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was found in the other extracts. A low correlation (R
2
= 0.05) was shown between total 
phenolic and total flavonoid content (data not shown). 
 
 Ex vivo antioxidant methods 
In order to have a deeper knowledge of the antioxidant property of these extracts, we also 
studied them using two experimental protocols based on the oxidation of human low 
density lipoprotein (LDL).  
TBARS assay measures the MDA formed as the split product of an endoperoxide of 
unsaturated fatty acids resulting from oxidation of a lipid substrate. It is postulated that 
the formation of MDA from fatty acids with less than three double bonds (e.g., linoleic 
acid) occurs via the secondary oxidation of primary carbonyl compounds (e.g., non-2-
enal) (Fernández, Pérez-Álvarez, & Fernández-López, 1997). The TBARS procedure is 
widely used for its simplicity even though the reaction is not very specific and conditions-
dependent.  
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Figure 25 The effect of the plant extracts on copper-induced LDL oxidation. 
LDL (25μg/ml) was incubated for 1 h at 37°C with 10 µM of Cu2+
 
in the 
absence (LDL ctrl) or presence of the different extracts. Oxidation was 
determined by TBARS. Results represent mean ± SEM of at least three 
experiments. (p < 0.05) 
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The results of the Fig. 25 show that at 10 µg/ml the Casimiroa extracts have no inhibitory 
effects on the TBARS formation, but at a higher concentration (20 µg/ml) the two leaf 
extracts showed a moderate inhibition, 54.47% and 45.02% for Ce2 and Cp2, 
respectively. At the same concentrations the Boswellia serrata extracts showed almost the 
same inhibition of about 38%. Otherwise, the Croton lechleri sap, at a very low 
concentration of 5 µg/ml, caused a significant decrease on TBARS formation (80.57%), 
while Ribes nigrum only at the high concentration of 1000 µg/ml inhibited the TBARS 
formation of a similar amount.  
To confirm the data obtained by TBARS assay, it was carried out also a continuous 
monitoring of oxidation of human low density lipoproteins based on the quantification of 
conjugated dienes performing a kinetic reading at 234 nm, at which conjugated dienes, a 
primary product of LDL oxidation, have an intense absorption. This method is more 
specific and sensitive; Fig. 26 shows an example of one of the kinetics performed with the 
extracts. The Croton lechleri clearly caused an inhibition dose-dependent of the human 
LDL oxidation in comparison with the control (without inhibitor). 
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Figure 26. Example of determination of conjugated dienes with increasing concentrations of 
extract of Croton lechleri  
 
The Tab. 6 reports the results of this assay expressed as lag-time, parameter which 
correlates with the period before the rapid increase of the conjugated dienes (see 
methods). Again, at low concentrations minor than 1 µg/ml Croton lechleri prolonged in 
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a concentration-dependent manner the lag-phase. The leaf extracts of Casimiroa (Ce2 and 
Cp2) mildly increased the lag-phase,  at the relatively low concentration from 2 to 7 
µg/ml; the seed extracts (Ce1 and Cp1) appear to be much less actives than the leaf 
extracts, showing a similar inhibition at an almost ten-fold higher concentration. Ribes 
nigrum and Boswellia serrata at the concentrations chosen in this test did not show any 
activity (Tab. 6). 
 
 
 
Table 6 Effect of the plant extracts on the lag phase of LDL oxidation. 
Extracts 
Concentration 
(μg/ml) 
Ctrl Lagtime 
(min)  
Lagtime 
(min) 
Rate of 
inhibition (%) 
SdD 
0.4 
195 ± 50 
220 ± 52 14.5 
0.6 260 ±109 32.5 
0.8 305 ± 121 58.6 
Ce1 
20 
198 ± 29 
222 ± 10 13.6 
30 336 ± 16 71.5 
Cp2 
3 
193 ± 24 
240 ± 30 24.4 
5 290 ± 41 50.1 
7 350 ± 75 82.0 
Cp1 
20 
239 ± 27 
264 ± 49 9.9 
30 319 ± 73 32.5 
Ce2 
2 
179 ± 43 
206 ± 39 14.9 
5 261 ± 48 47.1 
Rn 
200 
234 ± 7 
253 ± 41 8.5 
1000 243 ± 30 3.8 
Bs 
10 
234 ± 7 
246 ± 16 5.2 
15 257 ± 16 9.9 
Each value in the table is represented as mean ± SEM of at least three 
experiments. 
 
In order to investigate the inhibitory effect of these extracts on advanced glycation end-
products (AGEs), the final products of the non-enzymatic reaction between reducing 
sugars and amino groups in proteins, lipoproteins, and nucleic acids, a further research 
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step was carried out using an assay based on co-incubation of BSA with D(+)-glucose or 
D(-)-ribose and each extract. At the end of the incubation, the AGEs formation was 
measured by determining the fluorescence by excitation at 355 nm and emission at 460 
nm. 
The Fig. 27A shows the inhibitory effect of plant extracts on the glycation of (Bovine 
Serum Albumin) BSA, induced by 0.1 M ribose (5 days incubation), a potent glycation 
inducer. In this condition, it was observed a dose-dependent inhibition; at 50 µg/ml, 
Croton lechleri, Ce2 and Cp1 showed an inhibition of 18.07 ± 6.91%, 10.85 ± 7.04% and 
10.81 ± 4.25%, respectively, while the positive control aminoguanidine (50 mM) showed 
an inhibition of 56.77 ± 5.88%.  
 
 
B S A  +  R ib o s e
F
lu
o
r
e
s
c
e
n
c
e
 (
e
x
. 
3
3
5
, 
e
m
. 
4
6
0
n
m
)
C tr l A G 5 0 1 0 5 5 0 1 0 5 5 0 1 0 5 5 0 1 0 5 5 0 1 0 5 5 0 1 0 5 5 0 1 0 5
0
5 0 0
1 0 0 0
1 5 0 0
2 0 0 0
***
***
*
*
S d D C e 1 C e 2 C p 1 C p 2 R n B s
 g /m l
 
Figure 27A Effects of the extracts on the formation of AGEs resulting from BSA (50 
µg/ml) glycation induced by 0.1M ribose. Each value represents mean ± SEM of at 
least three experiments.  
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Figure 27B  Effects of the extracts on the formation of AGEs resulting from BSA (50 
µg/ml) glycation induced by 0.8 M glucose. Each value represents mean ± SEM of at 
least three experiments. 
 
The Fig. 27B represents the glycation of BSA induced by glucose, a more physiological 
but in the same time weaker in vitro glycation inducer. The incubation time was 
prolonged to 7 days and the concentration used in the treatment was increased to 0.8 M, 
in comparison to ribose. Aminoguanidine inhibited completely the glycation while all 
extracts showed a remarkable inhibitory effect on BSA glycation, even at low 
concentrations but no dose-response relation was observed probably due to the 
incompletion of the reaction. 
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DISCUSSION 
 
Cardiovascular diseases are the leading cause of deaths worldwide, though since the 
1970s, cardiovascular mortality rates have declined in many high-income countries 
(Fuster & Kelly, 2010). At the same time, cardiovascular deaths and disease have 
increased at a fast rate in low- and middle-income countries (Finegold, Asaria, & Francis, 
2013). The causes of cardiovascular disease are diverse but atherosclerosis and/or 
hypertension are the most common (Dantas, Jiménez-Altayó, & Vila, 2012). 
Oxidative stress, an imbalance between formation of reactive oxygen species (ROS) and 
antioxidants in vivo, appears to be important in both the early and later stages of the 
atherosclerotic process. ROS, which include free radicals such as superoxide anion 
radicals, hydroxyl radicals and non-free radical species such as H2O2 and singlet oxygen, 
are various forms of activated oxygen. These molecules are exacerbating factors in 
cellular injury, inflammation, cardiovascular diseases, diabetes and aging process. It is 
generally assumed that frequent consumption of plant derived phytochemicals from 
vegetables, fruit, tea and medicinal herbs may contribute to the shift of balance toward an 
adequate antioxidant status (Mahomoodally, Subratty, Gurib-Fakim, & Choudhary, 
2012). 
Several reports tend to show that numerous plant derived natural products are effective 
antioxidants, and many medicinal plants with a long history of use in folk medicine in 
different countries against a variety of diseases have turned out to be rich sources of 
antioxidants (Lee et al., 2005; Mathisen, Diallo, Andersen, & Malterud, 2002). The 
advantage of natural antioxidants is their safety and that large oral doses are well tolerated 
(Green, Brand, & Murphy, 2004). Many antioxidant compounds, naturally occurring in 
plant sources, have been identified as free radical or active oxygen scavengers. Recently, 
interest has considerably increased in finding naturally occurring antioxidant for use in 
foods or medicinal materials to replace synthetic antioxidants, which are being restricted 
due to their side effects such as carcinogenesis (Ito, Fukushima, & Tsuda, 1985). Natural 
antioxidants may protect the human body from free radicals and retard the progress of 
many chronic diseases as well as lipid oxidative rancidity in foods. Hence, studies on 
natural antioxidants have great importance. In the present investigation, we studied the 
antioxidant property of four extracts obtained from medicinal plants which have been 
used in folk medicine for centuries in the treatment of several diseases, so their possible 
application in the prevention of atherosclerosis could be an interesting reinforcement of 
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their use in ethnomedicine. “Dragon’s blood” is a bright red resin that is obtained from 
different species of four distinct plant genera; Croton, Dracaena, Daemonorops, and 
Pterocarpus. 
Croton lechleri Mull. Arg., own of Mexico, Venezuela, Ecuador, Peru and Brazil, is 
possibly the best-known source of this sap. When the trunk of the tree is cut or wounded, 
a dark red resin oozes out (RW.ERROR - Unable to find reference:172).  It is used in folk 
medicine as cicatrizing, anti-inflammatory (Pieters et al., 1993; Ubillas et al., 1994), anti-
microbial (Ubillas et al., 1994) and anticancer (Hartwell, 1969), as well as for the 
treatment of disorders of the digestive system (Ubillas et al., 1994).  
The antitumor, antimutagenic, antidiarrhoeal  and anti-inflammatory activities of Croton 
lechleri have been intensively studied, but few preliminary or partial studies on its 
antioxidant activity were documented in the literature in spite of the 90% of the dry 
weight of the sap is composed of phenolic compounds, including proanthocyanidins, 
catechin, epicatechin, gallocatechin and epigallocatechin (Cai et al., 1991). 
Casimiroa edulis Llave et Lex (Rutaceae) popularly called ‘Zapote blanco’, is a tree 
distributed in the temperate zones of Mexico and central America. The use of this plant in 
folk medicine is known from prehistoric times; its leaf or seed concoctions are taken for 
the sedative-like and sleep inducing effects (Romero et al., 1983). 
In early pharmacological researches, alcohol extracts of seeds (Magos & Vidrio, 1991) 
and aqueous extracts of leaves (Magos, Vidrio, & Enríquez, 1995) of Casimiroa edulis 
were found to have hypnotic, anticonvulsant and antihypertensive effect. In our previous 
work, the extracts of Casimiroa edulis and Casimiroa pubescens were revealed to possess 
a vasodilation activity on arterial vessel (Bertin, Garcia-Argaéz, Martìnez-Vàzquez, & 
Froldi, 2011). Therefore, we chose to further study the Casimiroa genus to determine its 
antioxidant activity for the possible use of these plant extracts in the treatment of CVD 
taking advantage of the dual action of vasodilation and antioxidant. 
The black currant (Ribes nigrum), a woody shrub in the family Grossulariaceae, is grown 
for its berries which are a rich sources of phenolic compounds such as flavonoids and 
other polyphenols. In folk medicine it was used in the treatment of arthritis, rheumatic 
complaints, diarrhea, spasmodic cough and has demonstrated a good anti-inflammatory 
property (EMA, 2010). 
Boswellia serrata (Burseraceae), an oleo-gum-resin obtained from a medium size tree of 
India, has been used for a variety of therapeutic purposes such as cancer, inflammation, 
arthritis, asthma, psoriasis, colitis and as hypolipidemic remedy. Its anti-inflammatory 
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property is widely documented while its antioxidant studies are few and often limited to 
some preliminary in vitro assays. So a more detailed study of the antioxidant activity is 
required as a complementary mechanism to the anti-inflammatory activity in the 
prevention of atherosclerosis. 
 
The DPPH• method is one of the most commonly used to determine antioxidant activity; 
it is based on the determination of the radical-scavenging activity. It measures the 
reducing ability of antioxidants toward DPPH• and is considered to be mainly based on 
an SET (single electron transfer) reaction, and hydrogen-atom abstraction is a marginal 
reaction pathway (Huang, Ou, & Prior, 2005). By this method, in this research, it was 
shown that the antioxidant activity varied widely between the extracts; the highest activity 
was presented by the Croton lechleri sap (EC50=2.74 µg/ml) with an activity comparable 
to that of ascorbic acid, a well-known antioxidant vitamin.  
Further, it was carried out also the ORAC assay of all the extracts and again the Croton 
lechleri showed the highest activity (TEAC = 5,74 x 10
3
 ± 0,64 x 10
3 
µmol/g). 
Differently, from DPPH· assay, the ORAC assay is based on HAT (hydrogen atom 
transfer) reaction and measures antioxidant inhibition of peroxyl radical induced 
oxidations and thus reflects classical radical chain breaking antioxidant activity by H 
atom transfer (Ou et al., 2001).  
Moreover, the four Casimiroa extracts (Ce1, Cp1, Ce2, Cp2) showed similar activity in 
both DPPH• and ORAC assays, and to be noted that in both assays the leave extracts (Ce2 
and Cp2) showed higher activity than the seed extracts (Ce1 and Cp1). 
We also observed  that Ribes nigrum demonstrated a higher activity in the DPPH· assay 
than in the ORAC assay, this may indicate that it acts as an antioxidant mainly by SET 
mechanism, and this was confirmed by its high value in the total phenolic content assay, 
which is also based on SET reaction (Huang et al., 2005). Since in the DPPH• assay, the 
two seed extracts of Casimiroa (Ce1 and Cp1), together with the extract of Boswellia 
serrata, showed a poor activity that did  not reached the 50% of inhibition and for this it 
was not possible to calculate EC50 values. It was observed that all extracts showed similar 
trend in both DPPH· and total phenolic content assays  This phenomenon may be because 
that first two assays share the same mechanism (SET), and second, phenols are 
responsible for the majority of the antioxidant activity in most plant- derived products (V. 
L. Singleton, Orthofer, & Lamuela-Raventos, 1999).  
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The phenolic compounds are found as a group of approximately 8000 natural compounds 
which have a phenol as a common structural feature (Shahidi, Janitha, & Wanasundara, 
1992). These compounds are divided into three major class, according to the number of 
phenol subunits in the molecule: 1) simple phenols – phenolics containing one phenol 
unit; 2) flavonoids – phenolics containing two phenol subunits; and 3) tannins – phenolics 
consisting of at least three phenol subunits. They act in plants as antioxidants, 
antimicrobials, photoreceptors, visual attractors, feeding repellants, and for light 
screening. Many studies have suggested that flavonoids exhibit biological activities in 
mammalian, including antiallergenic, antiviral, and anti-inflammatory. Also most interest 
has been devoted to the antioxidant activity of flavonoids, which is due to their ability to 
reduce free radical formation and to scavenge free radicals. The capacity of flavonoids to 
act as antioxidants has been the subject of several studies in the past years, and structure-
activity relationships have been established (Pietta, 2000).  
Several epidemiological studies provide support for a protective effect of the 
consumption of fresh fruits and vegetables against cancer (Ingram, Sanders, Kolybaba, & 
Lopez, 1997), heart disease (Gey, 1995), and stroke (Peterson & Dwyer, 1998). Thus, it is 
possible that also flavonoids contribute to the protective effect of fruits and vegetables. 
This possibility has been evidenced by several in vitro, ex vivo, and animal studies 
(Gorinstein, Bartnikowska, Kulasek, Zemser, & Trakhtenberg, 1998). 
Unfortunately, the humans trials are still limited and somewhat controversial (Wang & 
Goodman, 1999). Data on biological markers, such as blood levels of flavonoids and their 
metabolites, are not widely available, thus making it difficult to determine individual or 
combined role of the flavonoids in relation to other antioxidants (Pietta, 2000). 
In our study, we carried out a measurement of total flavonoid content by aluminium 
chloride method; surprisingly, the extracts of Croton lechleri and Ribes nigrum, which in 
the total phenolic content assay showed the highest values, were found to have a very low 
level of flavonoids, 0.41 ± 0.24 mg QE/g extract and 2.03 ± 0.18 mg QE/g extract 
respectively. This may be explained because the major components of these two extracts 
are proanthocyanidins (Croton lechleri) and anthocyanins (Ribes nigrum) that are 
oligomers of flavan-3-ol units linked mainly through C4 to C8 bonds, and glucosides of 
anthocyanidins (derived from flavonols, which lack the ketone oxygen at the 4-position) 
which do not directly react with aluminium chloride. 
DPPH• and ORAC assay are considered indirect assays of in vivo antioxidant capacity. 
They are very useful in screening studies because they provide often reproducible data. 
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The biological relevance of these methods has been argued, since the results of these in 
vitro assays could indicate the potential in vivo activity. Obviously, it should be 
underlined that the mentioned assays do not measure bioavailability, in vivo stability, and 
preservation of antioxidants in the tissues, and their reactivity in situ (Huang et al., 2005). 
It has been suggested that these assays may underestimate the real physiological 
antioxidant capacity of extracts (Serrano, Goñi, & Saura-Calixto, 2007). Anyway, since 
these measurements are rapid and easy to perform, they are widely used  for in vitro 
screening of antioxidant activity. It is argued that the use of various analytical methods 
for evaluation of antioxidant activity can lead to get more knowledge about antioxidant 
potentials of the studied compounds (Laguerre, Lecomte, & Villeneuve, 2007); therefore, 
we studied also the antioxidant activity of our plant extracts against the human Low-
Density Lipoprotein (LDL) oxidation, by conjugated dienes measurement and TBARS 
test.  
The oxidation of LDL is started by the copper-induced lipid peroxidation through the 
oxidative deterioration of polyunsaturated lipids. The initiation of a peroxidation 
sequence in a biological membrane as in whatever polyunsaturated fatty acid depends 
from the abstraction of a hydrogen atom from the double bond in the fatty acid. The free 
radical tends to be stabilized by a molecular rearrangement to produce a conjugated diene, 
which then easily reacts with an oxygen molecule to give a peroxy radical (LOO•). 
Peroxy radicals can abstract a hydrogen atom from another molecule or a hydrogen atom 
to give a lipid hydroperoxide, LOOH. A probable alternative fate of peroxy radicals is to 
form cyclic peroxides; these cyclic peroxides, lipid peroxides, and cyclic endoperoxides 
fragment to aldehydes including MDA and polymerization products. MDA is the major 
product of lipid peroxidation (Singh, Chidambara Murthy, & Jayaprakasha, 2002).    
The intermediate product of this propagation reaction is the conjugated dienes that has an 
absorption at 234 nm; thus, with a simple spectrophotometric reading, it can be followed 
the entire process of the LDL oxidation. While, with the TBARS test the entity of the 
oxidation was done by the determination of the MDA, final product of LDL oxidation.  
In conjugated dienes measurement, at the high concentration of ≥ 100µg/ml all extracts 
inhibited totally the oxidation process except Ribes nigrum, which even at very high 
concentration did not show a significant inhibition. Since LDL oxidation is based on HAT 
mechanism (Huang et al., 2005), this data could confirm that Ribes nigrum reacts as 
antioxidant mostly basing on SET reaction. Moreover, for a suitable comparison of the 
extracts, in the present experiments the concentrations of each extracts were chosen  in 
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order to obtain a complete three phase-curve for everyone in less than 10 hours; this assay 
is more sensitive but much more time consuming, the results obtained are in line with 
those obtained by the ORAC assay. And this confirm that these two assays share the same 
scavenging mechanism, the HAT reaction. While the TBARS assay is less specific, 
reason for which it is in some way criticized in literature; the no specificity probably 
results from the acid-heating step of the TBA assay that causes the formation of 
TBA/MDA-like derivatives (Liu, Yeo, Doniger, & Ames, 1997). Anyway, in TBARS at 
the concentrations of 10 and 20 µg/ml all extracts of Casimiroa genus and Boswellia 
serrata showed the same trend observed in diene conjugated determination, except for 
Croton lechleri which at 5 µg/ml inhibited significantly oxidation of LDL, while Ribes 
nigrum even at very high concentration (200 µg/ml) did not exert a significant inhibition.  
TBARS test and conjugated dienes determination are direct methods that are established 
on studying the effects of antioxidants on the oxidative degradation of a system for the 
biological relevance (individual lipids, lipid mixtures – oils, lipid membranes, low density 
lipoprotein, DNA, blood, plasma, etc.) (Roginsky & Lissi, 2005). Direct approach of 
evaluation that applies various lipid model systems rather than the indirect approach was 
preferred, where the antioxidant activity is assessed artificially by means of so called one-
dimensional antioxidant capacity (AOC)  assays (Laguerre et al., 2007). The kind of 
oxidative substrate in the model systems and the conditions of system play an important 
role for choosing the methods. Direct methods are often time consuming and they do not 
achieve the demand for quick and easy assessments.  
In the present study, it was also used a simple screening method to measure the inhibitory 
effects of the plant extracts on formation of fluorescent AGEs in vitro. AGE accumulation 
in vivo has been implicated as a major pathogenic process in diabetic complications, 
including neuropathy, nephropathy, retinopathy, and cataract and other health disorders 
such as atherosclerosis, Alzheimer’s disease, and normal aging. Thus, the discovery and 
investigation of AGE inhibitors might offer a potential therapeutic approach for the 
prevention of diabetic or other pathogenic complications (Peng et al., 2008). 
In our experimental system were used high concentrations of glucose to speed up the 
glycation reaction, thus allowing to undertake the glycation process evaluation in an 
appropriate time-scale, which it occurs very slowly under physiological conditions 
(Matsuura et al., 2002). Also, to simulate glycation, we repeated the same test using as 
glycation inducer the ribose, which is 100 times more potent than glucose (Baynes & 
Monnier, 1989). 
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Glycation of serum albumin has been widely studied in recent years, and bovine serum 
albumin (BSA) is commonly used as experimental substrate (Wei, Chen, Chen, Ge, & He, 
2009).  Given that our main focus was the study of the role of glycation on LDL in the 
pathogenesis of atherosclerosis, BSA was used as the protein in the glycation model,  this 
for two reasons: first, the protocol requires use of high amounts of protein (up to 50 
mg/ml) which was not possible to get with LDL from blood sampling; second, glycation 
of BSA and LDL are based on the same mechanism - glucose reacts with lysine residues 
of target proteins (Ghaffari & Mojab, 2010; Jahouh, Hou, Ková?, & Banoub, 2012).  
In the BSA-glucose protocol, all the plant extracts inhibited significantly the glycation, 
while in the BSA-ribose protocol only the Croton lechleri sap and two extracts of 
Casimiroa Cp1 and Ce2 inhibited significantly the formation of AGEs.  
 
The results obtained in this research work reinforced the claims made in ethnomedicine, 
giving good prospective of the use of these plant extracts; especially, the Croton lechleri 
sap and leaf extract of Casimiroa, in the prevention of the cardiovascular diseases and 
diabetic complications. In the future, more investigations of in vivo antioxidant effect and 
studies of cytotoxicity are needed. Further, these medicinal plants may also be used to 
find new compounds endowed with protective action against LDL oxidation and 
glycation, typical processes of metabolic syndrome. 
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